Rick Simpson Oil (RSO) dan Moris: Le Guide Complet par OilWell Cannabis

Byenvini, Moris. Nou lOilWell Cannabis, ek nou finn konstrir nou rekiltasyon dan Houston, Texas — ene parmi le marche kannabis ki pli avance medikalman ek pli konpleks legalman dan Amerik — kan nou finn refize vann lartifis. Nou kwar ki Morisien merite menm niveau dedikasion edikasyon onet, presizyon farmaseutik, ek klarte legal ki nou bay bann malad kanse, veteran, ek bann souferer douler kronik atrave LetaZini. Si ou pe rod RSO dan Moris, swa ou dan Port Louis, Beau Bassin-Rose Hill, oubyin Curepipe, se guide-la pou ou.

lor Rick Simpson ek RSO Tradisionel: Lisistoire Origine ki Sak Morisien Bizin Kone

Ki Moun Rick Simpson?

Rick Simpson ti ne dan 1949 dan Amherst, Nouvelle-Ecosse, Kanada. Pa ti dokter, pa ti sientis, pa ti profesionel medikal — ti ene jeyen plant pouvwar ek travayer lentretien, ene travayer kouler blue ki finn mars dan kannabis kan lamidisin tradisionel finn fer li defann.

Dan 1997, pandan li ti pe travay dan enpital dan Moncton, Simpson inn tonbe ek finn blese so latet gravite. Apre sa, inn ganny tinnitus persistan, vertiz, ek bann sintom post-concussion ki so bann dokter pa kapav resoud. Bann medikamen ki finn preskri pa ti ede oubyin inn fer so kondision pi mal. Kan kannabis finn donn li plis soulaz ki nanye ki so bann medsin finn prezante, li inn demann so dokter pou siporter oubyin preskrir li. Sa demand-la finn refize .

Lintere Simpson pou lwil kannabis konsetre inn renforci apre ki li inn aprann lor ene letid 1974 finanse par National Institute of Health ek realize dan Medical College of Virginia, koter THC ti raporter ki inn ralanti oubyin retire tumor kamarads. Sa letid-la — ki ti ete orizinelman pou montre domaz — inn vinn ene referans fondmanter dan latrayona Simpson pli tar, mem si so bann konklizyon pa finn replike dan letid kontrol kanse imen .

Moment pivotal dan listoire Simpson inn vini dan 2003. Li inn raporte ki trois bouton lor so bras finn diagnoze par so dokter kom karsinom bazal. Olie fer tretman konvansionel, Simpson inn aplike lwil kannabis konsetre direkman lor bann lesion, inn kouvri ar bandaz, ek inn atann. Selon so rapor, bann bouton-la finn disparait dan kat zour. Konteks ennportan: Pa finn pibliye okenn verifikasyon medikal independan de sa rezilta-la, ek okenn konfirmasyon biopsi oubyin swivi klinik finn dokumente dan nanye sous revise par bann ekspet. Sa eksperyans pesonel-la inn vinn listoire origin Rick Simpson Oil .

Sa sa vinn dir pou Moris: Istwar Simpson rezone atrave bann kiltir parski li koze ene eksperyans imen iniversal — letom par sistem medikal ek rod altirnatif. Dan Moris, kot lasante jeneneralman for me letan atann pou spesializasion kapav lontan ek bann opsyon medisin integrative limite, sa listoire-la kapav sanze familyer. Me konpran background Simpson-la kritik: li ti ene avoka, pa otorite medikal. So prevalans ti temwang pesonel, pa pruv klinik.

La Krozad — Gayn Lwil

Apre so eksperyans 2003, Simpson inn angaze totalman pou prodwi ek distribie lwil kannabis konsetre. Ki opere depi so propriyete dan Maccan, Nouvelle-Ecosse, inn koumanse fer lwil dan gran kantite ek domn li gratis bann malad kanse ek lezot dan so kominnite. Li pa ti charge nanye. Selon so prop rapor, li inn ede dizenn dimoun ar kondision inchiz kanse, douler kronik, dibet, enfeksyon, glaukom, artrit, depressyon, ensonmni, ek plis .

Istwar Simpson inn gayn ene odians global atrave dokumenter 2005 Run From The Cure, realise par Christian Laurette. Film-la finn dokumente bann reklamasyon Simpson, finn montre temwang bann dimoun ki li finn tret, ek finn formule so travay kom ene defi ras-root kont enteres farmaseutik ek gouvnermental. Finn distribie gratis online ek inn vinn ene parmi film pli largman partaze kanbis avokasi de so lepo .

Latrayona Simpson finn amenn li dirak konfli ar lwa Kanadien. Royal Canadian Mounted Police finn fer raz lapolis so propriyete dan 2005 ek 2009. Finn akiz li ar kiltivar, posesyon, ek trafik kannabis. Kan finn fer fas ak presyon legal kontinyel, Simpson finn eveni abandon Kanada ek deplase Lirrops, kot li finn kontinye so latrayona .

Dan 2012, Simpson finn pibliye Phoenix Tears: The Rick Simpson Story, ki detaye so eksperyans pesonel, procedir fer lwil, ek so lavi filozofik .

Pandan so karyer piblik, Simpson inn kontigny dir ki lwil kannasil kapav geri kanse ek boukou lezot maladi, ek ki bann konpagni farmaseutik, agans gouvnerman, ek enstitisyon medikal pe aktivman siprime sa konesans-la. Finn frame so travay kom ene lit kont koripsyon enstitisyonel .

Sa sa vinn dir pou Moris: Risk legal ki Simpson finn fase dan Moris mir sa ki bouku Morisien kapav per. Pandan ki Moris pa finn legaliz kannasil rekresyonel, bann produit sorgaz deriva ar mwins ki 0.3% delta-9 THC tom dan ene kategori legal diferan. Bann produit OilWell konform ar Farm Bill ek expor internasyonal avek dokimantasyon konpli. Sa klarte legal-la se sa ki Simpson pa finn perna.

Protokol RSO Tradisionel — Regim 60-Gram, 90- Zour Simpson

Rekomanndasyon tretman primordial Simpson ti ene protokol oral strukture konsepuir pou delivre 60 gram lwil kannabis konsetre sou environ 90 zour. Finn dekrir sa kom ene protokol tretman kanse, me li finn osi rekomannde li pou boukou lezot kondision .

Objektif

Konsom 60 gram lwil kannabis konsetre, THC-lot, sou environ 90 zour. Simpson konsidere sa kantite minimom neseser pou ene bon kou tretman kanse serye.

Or Titrasyon

• Semenn 1: Komanse avek ene doz grander mwatye grain dir riz — apepres 10 a 15 miligram lwil — pran trwa fwa chak zour. Total konsomasyon chak zour: apepres 30 a 45 miligram.
• Semenn 2-5: Doubl doz apepres chak kat zour pou bati tolerans THC gradielman. Akoz fin sa peryod-la, objektif se apepres 1 gram (1,000 miligram) lwil chak zour, divize an trwa doz.
• Semenn 5-12: Mantien doz konpli apepres 1 gram chak zour, divize an trwa doz apepres 333 miligram chak, ziska konsom total 60 gram.

Metod Administasyon

• Primordial — oral: Plas doz diraman anba lalang (sublingual) oubyin vale. Simpson konsidere ingestyon oral rout pli importan pou absorpsyon sistemik.
• Sekonder — topikal: Pou kanse lapo ek lesion ekstern, aplike lwil diraman lor zon afekte, kouvri avek bandaz, ek sanz chak trwa a kat zour. Finn konbine aplikasyon topikal ek doz oral pou kanse lapo.
• Pa rekomannde kom primordial — inhale: Simpson pa ti rekomande fimen oubyin vaporyze lwil kom metod tretman primordial, me rekonet li pou soulaz imedyat sintom.

Tolerans ek Efet Psikoaktif

• Simpson ti kontigny ki bann malad finn devlop tolerans siyifikatif pou efet psikoaktif THC dan trwa a kat semenn.
• Finn konsidere efet ewforik, sedatif, oubyin dezorant kom ene efet seconder miner ek temporere ek ti enkuraz bann malad pa les lenkouraz par lasay.
• Finn rekomande doz initiale aswar oubyin avan dodo pou dormi atrave efet psikoaktif pli intens.
• Simpson osi ti rekomande ki bann malad evit kondwit oubyin opera masinn pandan peryod titrazon.

Mantenans Apre Protokol

Apre fini kou konpli 60 gram, Simpson ti rekomande ene doz mantenans apepres 1 a 2 gram lwil chak mwa, pran san limitasyon.

Konteks Enportan Pou Evalye Sa Protokol-la

Sa protokol finn konsepuir par ene senn dimoun baze lor so eksperyans pesonel. Pa finn devlop atrave letid klinik, letid pou trouv doz, oubyin rechech formal. Enpe pwen kritik aplikab:

• Okenn validasyon letid kontrol. Pa finn pibliye okenn letid aleatory kontrole, letid koh, oubyin seri ka byen dokumente ki evalye sa protokol spesifik 60-gram/90-zour-la pou nanye kondision.
• Sipoz material brut, non-standarize. Kantite 60 gram la sipoz ene ekstrak single-strain, dominn-THC san presizyon puissance. Kontenu THC aktiel varie lareman.
• Ekspozisyon THC tre hau. Akoz doz pik, bann malad konsom apepres 1 gram lwil THC-lot chak zour. Si puissance 60-90% THC, sa reprezant apepres 600 a 900 miligram delta-9 THC chak zour — ene doz ki depas lareman nanye etidye dan kontek klinik kontrole. Pou referans, dronabinol (THC sintetik) aprouve FDA tipikman dose 2.5 a 20 miligram chak zour.
• Risk real akoz sa bann doz-la. Konsom 600 a 900 miligram THC chak zour transport risk grav incliw intoxikasyon sever, diminisyon, anksiyete, panik, tachycardia, hypotension, ek disorder itiliz kannabis [1][13][14][15].
• Konteks onkolozi. Bann malad avek kanse aktif souvan medikalement konpleks. Servi lwil kannasil non-regulate, non-standarize kom tretman kanse primordial — potensielman o plas tretman prouv — introduir domaz ki depasse lwil-la mem.

Sa sa vinn dir pou Moris: Bann malad kanse Morisien, souferer douler kronik, ek bann kitwaye ki pe rechech RSO online finn kontra ek protokol Simpson. Bizin konpran siyifikasyon istorik li ek so limitasyon. Bann doz depas lareman sa ki nenport klinisien kapav rekomande, ek produit-la pa finn standarize oubyin teste. Se la ki lapproche modern OilWell vinn essensiel.

Ki Sa Tradisionel Rick Simpson Oil — Produit-la

RSO tradisionel refer an spesifik kalite lwil kannabis konsetre ki Simpson ti fer. Finn defini li pa lab spesifikasyon me par so metod.

Material sous: Bann varite kannabis THC-lot, indica-dominnan. Pa finn standarize varite — material depa varie disponibilite ek sezon kiltiv.

Solve ekstraksyon: Naphtha (solve petrole) oubyin alcool isopropyl 99%. Okenn kalite pa bon pou manze. Naphtha kapav kontenen benzene, toluene, ek lezot konpose toksik oubyin kansejenn. Evaporasyon solve inkonpli kite rezidu potensialmant danze.

Proses ekstraksyon: Material plant inn dibezin dan solve, filtre, ek evapore dan rice cooker a temperati sifizan pou dekarboksil THCa an THC ek detrir laplipar terpene.

Laparans: Lwil for, prese noir, epes kon goudron avek fotman kannabis for ek posib fotman rezidu solve.

Profil kannabinoid: Dominan-THC (60-90% estim), totalman dekarboksil, avek kannabinoid minor a proporsyon natirel — non-kontrole, non-mizire, pa lab-verifie.

Kontenu terpene: Minimim a okenn. Konbinezon ekstraksyon solve ek evaporasyon lo-choz finn retire terpene dan produit final.

Standarize ek test: Okenn. Sak prepazasyon diferan. Pa finn Certificate of Analysis (COA), pa kantifikasion kannabinoid, pa kontrol kontaminant.

Risk rezidu solve: Siyifikatif. San test lab, imposib verifie remu solve konpli.

Sa sa vinn dir pou Moris: Si ou dan Moris ek ou trouv ene produit etikete “RSO” dan marche lokal oubyin online, li posib ki li porte ti kalite ar sa ki Simpson ti vremem fer — ek sa pa neseserman move. RSO modern evolye bouku. Lakle se konpran sa ki ou aktielman pe ganye: ene produit standarize, teste oubyin ene ekstrak brut, varyab.

Bann Reklamasyon Simpson vs. Lis Evidans

Simpson ti reklam ki RSO kapav geri kanse ek boukou lezot maladi. Pa ti indecis, ti konsistan, ek piblik lor sa bann reklamasyon-la pandan so karier avokasi .

Ki Simpson Pa Ti

Pa ti sientis, dokter, farmakolog, oubyin recheche. Pa ti finn formasyon medikal, onkolozi, farmakolozi, oubyin metodolozi rechech klinik. Pa inn designe, realise, finanse, oubyin pibliye ene letid klinik. Pa finn soumet so rezilta pou revizyon par bann koly. So baz evidans konpli ti konpran eksperyans pesonel, rezilta malad ki finn raporte limem, ek temwang ki finn kolekte informelman — san kontrol, san verifikasyon independan, san konfirmasyon imaz, san swivi lontan, ek san aveg.

Ki Lis Literati Preklinik Montre

• Letid in vitro finn demonstre ki THC ek CBD kapav indik apoptosis (lamor sel program), inhibit proliferasyon, ek reduisyon angiogenesis dan sertenn lign sel kanse .
• Letid model animal finn montre sertenn inhibit kwasans tumor kamarads ke trete ar kannabinoid .
• Sa bann konklizyon-la finn jenere linte sientifik legitime ek rechech kontinie.

Ki Lis Literati Preklinik PA Montre

• Sa bann konklizyon-la pa tradwi an gerizon kanse imen prouv. Gap ant rezilta in vitro oubyin animal ek rezilta klinik imen vast.
• Okenn letid klinik imen pa finn demontre ki RSO oubyin nenport preparasyon lwil kannasil kapav geri kanse.
• Kelke ti letid klinik imen lor kannabinoid dan konteks kanse (partikilyerman glioblastoma) finn realize, me realite eksplorater, ti, ek pa finn prodwi kalite rezilta ki kapav siporter reklamasyon gerison kanse .

Pozisyon Enstitisyonel

• U.S. National Cancer Institute (NCI): Rekonet ki kannabinoid finn etidye pou potansiel efet antikanse dan model lab ek animal me pa endosse kannabis oubyin lwil kannasil kom tretman kanse .
• U.S. Food and Drug Administration (FDA): Pa finn aprouve nenport produit kannasil bann plant pou tretman kanse. Seulman produit derive kannasinoid ki finn aprouve: Epidiolex (CBD) pou sertenn disorder konvulsion, ek dronabinol/nabilone (analog THC sintetik) pou nawze kemoterapi ek kesperdy perdi [1].
• Sante Kanada: Pa finn aprouve RSO oubyin lwil kannasil kom gerizon kanse.
• NCCIH: Deklar eksplisitman ki evidans ki pli for pou kannasinoid se pou epilepsi rar, nawze ek vomisman kemoterapi, ek indikasyon appeti dan HIV/AIDS — pa gerison kanse [1].

Ki Simpson Finn Gagn Dwa

Simpson finn tir latansion sou kannabinoid kom ene domain serye rechech biomamedikal dan ene moman kot lemond antye ti pe ignorer oubyin aktivman siprime konversasyon-la. So latrayona inn ede kreye kondisyon politik, kiltirel, ek sosial pou endistri kannasil legal ek linfrastriktir rechech kannabinoid ki egziste zordi. Li ti parmi premie ki finn amenn lwil kannabis konsetre dan latansion piblik lareman, ek termin RSO li-mem res most konu pou ekstrait kannabis full-spectrum.

Ki Li Finn Exajere

Sotir preklinik siperyor a gerizon kanse pa ti siporter par evidans imen kan Simpson inn formule li, ek li pa siporter zordi. Inkouraz bann malad — partikilyerman malad kanse — pou konte lor RSO kom tretman primordial o plas tretman onkologik prouv transport risk domaz veritab. Tretman retarde oubyin abandonne pou kanse traitab se ene preokipasyon dokumente dan literati medisin altirnatif.

Sa sa vinn dir pou Moris: Bann malad kanse Morisien ek zot fami merite onntete. Lesperans ki RSO ofer se real ek puissan, me li bizin ankre dan evidans, pa promeses fals. RSO bizin konplete swen medikal, pa ranplas li. Si ou pe fer tretman kanse dan Moris dan SSR National Hospital, Jawaharlal Nehru Hospital, oubyin nenport klinik onkologi prive, diskite nenport itilizasyon kannabinoid ar ou onkolog. Lasians interesan. Bann reklamasyon gerizon pa finn prouv.

RSO Tradisionel vs RSO Modern Formile

Dimenzyon	RSO Tradisionel	OilWell RSO Formule
Material sous	Single varite indica THC-lot	Melanj multi-kannabinoid depi boukou sous
Metod ekstraksyon	Naphtha oubyin alcool isopropyl	Metod modern etanol kalite aliman oubyin CO₂
Profil kannabinoid	Dominan-THC, non-kontrole	Seet kannabinoid definis a proporsyon spesifik
Kontenu terpene	Detrir par proses lo-choz	Terpene vivan a 5% avek profil terpene-seet definis
Standarize	Okenn — sak lot diferan	Teste lab avek objektif mg/mL spesifik
Test lab	Pa disponib oubyin realize	Panel test konplen
Solve rezidu	Risk siyifikatif ar naphtha	Kontrole ek teste
Presizyon doz	Epromisime, base serinnz	Mizire par mL avek kontenu kannabinoid konnu (553 mg/mL)
Formats produit	Selman lwil for	Lwil sublingual ek kartouche vape avek formil spesifik pou format
Prezervasyon THCa	Non — totalman dekarboksil par choz	Wi — THCa enkli kom engra indepandan a 1,500 mg
Apwoche evidans	Anedot, temwang pesonel	Base rechech, poid evidans

Poukwa Bann Formil OilWell Diverz ar RSO Tradisionel

Apwoche multi-kannabinoid: RSO tradisionel ti konte selman ar sa single varite ki preparater ti kiltive. Bann formil OilWell inklir siz kannabinoid parski literati entourage-effect suzere potansiel benefisite divesite kannabinoid, mem si pruv robust klinik synerzi formil antie pa limite [20][29].

Prezervasyon ek ajoute terpene: RSO tradisionel pa ti pratikman kontan terpene. OilWell inklir terpene vivan a 5% avek profil terpene-specific-seet parski bioaktivite terpene plozib ek sipoze dan nivo preklinik [20][21][23][24][25][26][27][28][29].

THCa kom engra indepandan: RSO tradisionel finn dekarboksil tu. Formil sublingual OilWell inklir THCa a 1,500 mg kom engra indepadan, prezerv prekarsor asidik paske literati THCa suzere potansiyelman bioaktivite non-psikoaktif pertinan ki perdi kan THCa konverti an THC [12].

Rediksyon dominasyon delta-9 THC: RSO tradisionel ti 60-90% delta-9 THC. Formil sublingual OilWell servi delta-9 THC selman a 90 mg pandan ki delta-8 THC a 6,000 mg ek distribie leziter kontenu atrave CBD (4,500 mg), CBG (3,000 mg), CBN (750 mg), ek CBC (750 mg).

Innovasyon format produit: Simpson ti vizionne selman ene format: lwil oral depi serinnz. OilWell ofer ene lwil sublingual 30 mL ek ene kartouche vape 1 gram, sak avek formil spesifik format, rekonet ki diferan rout delivrans ena diferan profil farmakokinetik [14].

lor OilWell Cannabis ek Formil RSO OilWell

Loriginn OilWell Cannabis

OilWell Cannabis ti fonde par Colin Valencia dan Houston, Texas. Colin ti grandi dan McAllen, Texas — dirak river Reynosa, Tamaulipas, Meksik. Zon McAllen-Reynosa, konu kom Borderplex, se ene parmi pli defavorize ekonomikman ek pli danze long kordonn U.S.-Meksik. McAllen se ene vil kontra — kiltir vivant ek ene sekter konmersyal prosper, me forteman afekte par lamizer ek opportinite limite andeor konmersyal ek lasante. Reynosa, lot kote, se ene sant endistriyel angaze avek vyolans ek aktivite kartel, ki fer li enenvironman dir pou nenport ki grandi la.

Lenfance Colin dan McAllen ti karakterize par exposisyon ar opportinite ek defi lavi long kordonn. Bitam, li inn aprann konbat, pran risk dan transport bann item atrave kordonn pou diferan group. Sa bann eksperyans prematir la finn expose li laplenn danze. Boukou so bon kamarad finn tuye oubyin dan prison akoz bann danze asosie. Li finn fas tu form vyolans posib, dan lari ek atrave kordonn. Ar setzan, dan ene fason ou lezot, li ti bizin kite lakaz pou bon.

Malgre bann danze, Colin pa ti tonbe dan pli move chemen disponib, tankou vann drg pli dir. Olie sa, li ti konsantre lor kannabis, konsider li kom ene altirnatif pli an sekirit ek pli benefis. Li ti grandi dan mond kannasil tradisionel lontan avan legalizasyon, aprann plant intimeman pandan ki li ti opere dan lonbraz. Avek letan, li finn transisyon depi sa bann premie entreprice risker-la ver kreyasyon ene biznes legal, legitim dan ene endistri ki li kwi.

Colin pli tar vin en jeyen developman lojisiel formelman ek ti fer travay devlopman koutom pou Baylor College of Medicine, ene parmi pli prestizie enstitisyon medikal dan Texas Medical Center. Sa konbinezon — konesans profon plant kannasil ek presizyon teknik kalite medikal — finn definir eventually lapproche OilWell.

Sa sa vinn dir pou Moris: Liswar Colin pa konsern privilege oubyin sipor konporativ. Li koze sou viv, entegrite, ek konstriksyon enn za real atravers difikilte. Dan Moris, kot bann kominn vale rezilyans ek otantikite, sa istori origin-la enportan. Pa enn konporasyon san fas; se enn konpagni konstriye par enn dimoun ki konpran sufra ek pa finn les lezot pas san opsyon.

Liswar Bentley: Veritab Rezon Ki OilWell Egzist

Liswar konpagni-la koumans ar enn lesyen apel Bentley. Bentley ti plis ki zis ene bet — ti enn manm family, ene konpanyon ki ti kanpe ar Colin pandan lepok pli difisil. Kan Bentley inn tom malad grav, bann veteriner finn livre verdik ki okenn pwopriyetier lezanimo pa envi tann: eitansi se selman opsyon imen. Bentley ti paralize so de lapat deye. Finn dir ki medikaman douler finn detrir so bann organ andeor, ki finn fer li pli mal ek pli soufer. Se te swa devine soufrans long e penible oubyin eitansi imedyat.

Me abandone Bentley pa ti enn opsyon. Colin finn ganny bouku pert ek finn ganny bouku soufer dan so lavi. Bentley ti enn konbatan, parey kou li, ek Colin pa ti pre pou les li al. Dan ene rechech desesper ar altirnativ, li finn stumble lor propiyete gerizon CBD — ar ene kestyon ki inn toultu tu.

Enn travayer sekour apel Jessica inn dimann Colin: “To finn deplase konbyen ton kannab ek to zame pa tande parle CBD?”

Colin ti ena eksperyans kannabis — me rekreasional. Gayn lor. Li zame inn eksplore aplikasyon terapeutik ek medikal. Kesyon Jessica-la inn expose ene borg ki inn vinn ene misyon.

Determine pou sov Bentley, Colin inn aprann kreye golden paste CBD — ene formil kannasinoid spesialize pou bet. Pa ti ene gerizon, me ti ene lifeline — ek ti lesperans. Ek sa lesperans-la finn donn enpossib: Bentley leve. Li mars ver Colin ek inn amenn li so bal pou zwe. Depi paralize ek fas eitansi, ver kaport so bal. Sa pa ti efet placebo — bann lesyen pa reponn placebo. Sa te kannasinomedisin ki finn fer sa ki farmaseutik pa kapav.

Bentley ti viv dis an plis, fini vivan dan setzan. Pandan sa dis an-la, Colin finn devlop formils kannabis spesialize pou sak kondisyon lage ki Bentley finn fas. Nourodegnerasyon finn amenn li konpran propriyete neuroprotektif CBG ek PPARγ agonism THCa pou proteksyon selil sek. Dementia finn amenn li konpran rol CBC dan neurogenese. Glaukom finn amenn li konpran CB1 agonism THC pou reduksyon presyon ntrinye. Artrit dezablan finn amenn li devlop bann apwoche anti-inflammatwar multi-sipon ki servi CBD, CBG, THCa, ek bata-karyophyllene travay atrave diferan sistem respeter similtane.

Kannabinoid sekser pa ti ase. Bann kondisyon evolyan Bentley ti bezwen synerzi multi-kannabinoid. CBD sel pa ti kapav adrese nourodegnerasyon ek dementia ek glaukom ek artrit similtane. Kannabinoid minor kuma CBG, CBN, ek CBC vinn kritik kan Bentley vi vye. Presizyon farmaseutik ti enportan — lavi Bentley ti depann presizyon formil, pa devinet.

Sa sa vinn dir pou Moris: Dan Moris, kot bann bet souvan konsidere family, liswar Bentley rezone profonman. Sak Morisien pwopriyetier lezanimo konpran moment veteran di pa ena plis nanye pou fer. Liswar Bentley donn lesperans fond lor rezilta real. Me pli enportan, dis an konesans formulatin ki Colin finn bati pou garde Bentley viv se FONDASON formil RSO ki Morisien kapav aksede zordi. Sa pa ti rechech teorik — sa te dis an test real lor ene malad ki li plis ki nanye.

Leksperyans Pesonel Colin: PTSD, Adiksyon Benzo, ek Peace Gummies

Colin osi konn depandans farmaseutik pesonelman. Li ti gouman ar PTSD ek adiksyon benzodiazepine. Kan deside libere ar Xanax, li finn fer li sans rap (cold turkey) — ene exploit ki notwar difisil ek danze — servi konesans kannabinoid ki li finn devlop kan fer sa Bentley viv. Formil Peace Gummies ki finn vinn ene produit OilWell ti kreye pandan enn esperimant minwi pandan ki li ti pe gouman kont siyomman benzo. Pou asire soulaz rapid, OilWell osi ofer formil Peace Gummies dan form vape, ki Colin itiliz pesonelman pou geri so ensonmni ek PTSD sever. Sa pa konesans teorik. Colin finn viv sa ki bann malad RSO viv: desesperasion pou soulaz, farmaseutik ki pa mars, dekouver ki kannabinoid mars kan bann konprime pa mars.

Sa sa vinn dir pou Moris: PTSD ek adiksyon benzo egziste dan sak kominn, Moris inkliz. Veteran, sirvivant trauma, ek dimoun pike dan sik preskripsyon finn rekonet sa eksperyans-la. Leksperyans pesonel Colin fer OilWell kredib pou sa bann popilation-la dan enn fason ki okenn konpagni korporativ pa kapav. Kan ene kliyan Moris avek anxiyete oubyin PTSD kontakte nou, li pe koz ar enn dimoun ki finn mars sa chemen-la.

Bann Dokter Itiliz Nou Bann Formil

Avek letan, benefis terapeutik kannabis ki Colin inn dekouver atravers so efors pou sov Bentley vinn lespri de so travay. Li finn devlop bann formil ki bann dokter itilize pou kondisyon kuma maladi Crohn, IBS, ulcer colit, PTSD, adiksyon benzo, ek ensonmni. So fokis touletan ti lor fer kannasil aksesib ek efikas pou tu dimoun, inkliz vegan, dibetik, ek sa ki genyen bezyn lasante spesifik.

Sa sa vinn dir pou Moris: Dan Moris, kot medisin integrative pe grandi me ledikasyon kannabis limite, fakta ki vremem bann dokter itiliz sa bann formil-la se ene kredibilite siyifikatif. Si ou ene founise lasante Moris ki pe eksplore opsyon kannabinoid pou bann malad, ou pa pe seul. Bann formil OilWell finn design pou presizyon klinik.

Rekonpans Medya ABC13: Sept Segment, Kat Zan, Enn Sel Lavwa

Ant Septanm 2019 ek Avril 2023, ABC13 Houston (KTRK) — affiliate ABC ki servi katriyem pli gran vil LetaZini inn kary Colin Valencia ek OilWell Cannabis dan sept segment disink devlope kouvers biznes, lwa, medsin, lasante kominn, ek politik. Senk diferan jounalis ABC13 finn rod Colin pandan sa bann anne-la: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, ek ekriven KTRK staff. Okenn lot operater kannabis Houston pa aparit ar sa frekans oubyin travers sa leze suje pandan mem peryod.

Sa sa vinn dir pou Moris: Validasyon medya mainstream depi ene gwo marche ABC affiliate etabli kredibilite ki transandzeografik. Kan bann Morisien trouv ke ene organizasyon nwarz Houston — dan katriyem pli gran vil Amerik, lakaz pli gran konpleks medikal mondial — repete seleksyon Colin kom prensipal ekspert kannabis, sa demontre enn nivo konfyans ki okenn kampagn marketing pa kapav replike. Sa se verifikasyon ters parte de ekspetiz, etik, ek angajman kominn.

Bann segment finn dokumente:

• Septanm 2019: Biznes CBD pe bum (sitasyon fondamental: “Mo pa pe esey vann bann dlo serpan”)
• Mars 2021: Ekozistem antrepran ek desriminalizasyon
• Me 2021: Enket delta-8 THC (“Petet ou envi gayn lor” — onntete sans sansir)
• Out 2021: Distribisyon gratis vaksin COVID (1,000 caviar pre-rolls, ~$35,000 dan produi done)
• Oktob 2021: Entrediksion delta-8 (retrait proaktif, avetisman lezot operater)
• Oktob 2022: Paradon marijuana Biden (listwar konviksyon pesonel Colin revle)
• Avril 2023: Lwa marijuana Texas ek “Renaissance” endistri

Sa sa vinn dir pou Moris: Lakordatrwa ar sa bann segment-la montre konzistans, leze ekspetiz, aksyon kominn, ek risk pesonel. Pou kliyan Moris ki pe evalue si konfye ene konpagni base LetaZini, sa dosye medya demontre ki OilWell finn gan verifike par jounalis independan pandan kat an — rekonpans ki pa kapav ashte.

Operasyon Aktiel: Houston-Fabrike, Moris-Aksesib

Zordi, OilWell Cannabis opere depi Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). Konpagni-la opere depi 2019, jenere apepres ene milyon dolar dan revnu annyel, menten preske rating Google 5.0, ek li Texas DSHS lisiansie. Tout lasenn, bann formil, ek anbalaz finn kree lakaz dan Houston, servi selman bann rese OilWell.

Sa sa vinn dir pou Moris: Pandan ki nou fizikman base Houston, nou bann produi aksesib Moris. Nou expor internasyonal avek dokimantasyon konpli, Certificates of Analysis, ek sipor douane. Ladres ek lisiance Houston nou verifaye — nou pa ene operasyon vole. Kan ou kmande depi Moris, ou recev ene produi fabrike dan kapital medikal Amerik, sipar pa kat an kredibilite verifie par medya.

Filozofi OilWell RSO: Kat Prinsip Kler pou Moris

1. Aksesibilite Olye Gatekeeping

Pa bezwen kat medikal. Nenen ditwa lage vinteyen-an ou plis kapav aste. Nou expor patou atrave LetaZini ek internasyonal Moris ek lezot peyi kot bann produi derive sorgaz avek mwins ki 0.3% delta-9 THC finn permit. Simpson ti kwar ki medikaman bizin aksesib tu dimoun; nou finn bati ene produi ek model distribisyon ki fer sa aksesib legalman.

Pou bann kliyan Morisien: Ou pa bezwen preskripsyon oubyin otorizasyon medikal. Ziska kan Moris permet importasyon bann produi derive sorgaz avek delta-9 THC minimal, ou kapav kmande dirtekman. Nou bay tout dokimantasyon pou douane.

2. Puissance Kontrole par Malad

THCa vann dan so form asidik, non-psikoaktif. OU deside si ou itiliz li brut pou benefis non-psikoaktif oubyin dekarboksil li an delta-9 THC pu plenn puissance psikoaktif. Simpson ti kwar ki malad bizin kontrol zot prop medikaman; nou finn jeyen ene produi ki met sa kontrol-la dan ou les par chimie.

Pou bann kliyan Morisien: Sa se flexibilite revolutioner. Si ou travay dan sekter touris, svis finansie, ou nenport travay ki bezwen klarite mantal, ou kapav itiliz form brut pandan zour avek zero diminisyon. Si ou bezwen plenn fors terapeutik pou douler/purir aswar, ou kapav dekarboksil lakaz. En sel produi serv plizir bezwen.

3. Formil Avek Source Owver

Nou pibliye nou bann formil konpli piblikman — sak kannabinoid, sak montan miligram, sak pourcentaz — pou ki nenport ki pa kapav pey produi kapav sours engra ek fer zot prop versyon. Simpson ti donn so lwil gratis ek ti anseyn dimoun kuma fer li; nou finn adapte sa etos-la pou marche modern.

Pou bann kliyan Morisien: Bann formil konpli finn pibliye pli tar dan sa guide-la. Si ou dan Moris kot kout importasyon oubyin frè livrezon fer produi-la proibitif, ou ena resèt-la. Nou pa gatekeep konesans. Sa se promes OilWell.

4. Base Evidans, Pa Exajer Evidans

SEKSYON KONESANS JENERAL dan dokiman-la reprezante nou angajman pou edikasyon onet lor sa ki lasians dir vremem. Simpson ti opere san aksè literati revise par bann koly; nou ena sa aksè-la ek nou servi li pou distenge entre sa ki bien siporter, sa ki pe emerz, ek sa ki exajere.

Pou bann kliyan Morisien: Dan ene marche kot reklamasyon kannabis souvan devans evidans, nou donn ou rechech real — 29 sitasyon revise par bann koly, evalyasyon nivo evidans, ek avetisman kler lor sa ki nou konn ek sa ki nou pa konn. Ou merite nenport mwins.

Konformite Farm Bill ek Kad Legal THCa pou Moris

Akt 2018 Farm Bill (Agricultural Improvement Act) legalize sorgaz ek bann produi derive sorgaz kontenant mwins ki 0.3% delta-9 THC par pwa sec nivel federal LetaZini. Sa kad legal-la se fondasyon nou design produi RSO.

RSO Lwil Sublingual nou konten selman 90 miligram delta-9 THC dan boutey 30 mL antie — 3 miligram par mililit — byen anba swiy 0.3%. Tou kannabinoid derive sorgaz. Produit-la legal selon lwa federal LetaZini.

THCa — asid tetrahydrocannabinolic — se prekarsor asidik, non-psikoaktif pou THC. Li pa li-mem delta-9 THC. Sa distinksyon-la legalman siyifikatif: THCa konform Farm Bill akoz lavant parski li pa finn konverti delta-9 THC.

Siyifikasyon pratik pou Moris: Ou kapav legalman aste nou produi selon lwa LetaZini. Kan li arive Moris, ou responsab pou konform ar lwa Moris lor bann produi derive sorgaz. Nou expor avek dokimantasyon konpli, Certificates of Analysis (COA), ek resi. Bann kliyan internasyonal aksepte tout responsabilite douane ek legal.

Avetisman legal enportan pou Moris: THCa konverti delta-9 THC kan choz. Lwa Moris kapav traiter produi konverti diferan ki produi brut. Nou konseye tou kliyan Moris pou verifye regleman lokal avan dekarboksilasyon. Nou produi legal pou export depi U.S. ek import Moris selman si lwa Moris permet bann produi kannabinoid derive sorgaz. Ou asime tou responsabilite legal pou ou itilizasyon ek nenport desizyon dekarboksilasyon. Annile kot prohibe par lwa Moris.

Chwa Dekarboksilasyon — Puissance Kontrole par Malad pou Moris

RSO tradisionel touletan finn dekarboksil total. Chale evaporasyon solve finn konverti tu THCa an THC, ki kite malad san okenn chwa lor psikoaktivite — lwil la touletan psikoaktif.

Formil sublingual nou konten 1,500 miligram THCa dan so form asidik, non-psikoaktif. Sa kreye twa opsyon itilizasyon distink pou bann kliyan Morisien:

Opsyon 1 — Brut, okenn choz. Tou 1,500 miligram res THCa — totalman non-psikoaktif. Profil evidans THCa dekri potansiel aktivite anti-inflammatwar via inhibit COX-2 ek potansiel neuroprotektif via PPARγ agonism [12]. Sa opsyon-la konpatib avek travay, kondwit, ek itilizasyon zour avek zero diminisyon psikoaktif.

Opsyon 2 — Totalman aktive, dekarboksilasyon lakaz. Chofaz lwil a 260°F (125°C) pandan 45 a 60 minit dan ene resipyan ki kapav al for konverti 1,500 miligram THCa an apepres 1,315 miligram delta-9 THC. Anplas 90 miligram delta-9 THC deja dan formil, sa donn apepres 1,405 miligram delta-9 THC total. Anplas 6,000 miligram delta-8 THC, produi aktive la ase puissance psikoaktif komparab ar RSO illegal tradisionel — 100% legal, parski dekarboksilasyon arive selon ou disrezion apre lavant dan Moris.

Opsyon 3 — Vape, otodekarboksilasyon. Kartouche RSO Vape vapore a 400 a 450°F, ki imedyatman konverti THCa an delta-9 THC akak bouf. Sak puff delivre kannabinoid dekarboksilize fèk. Sa se rout delivrans RSO pli rapid ki egziste.

Chimi konversyon: THCa ena en pwa molekiler 358.47 g/mol. Ratio konversyon se apepres 1 miligram THCa = 0.877 miligram delta-9 THC apre dekarboksilasyon, reflet pert molekil CO₂ pandan reaksyon.

Sa sa vinn dir pou Moris: Sa design-la met desizyon puissance total dan ou le — aliyen ar prinsip Rick Simpson ki malad bizin kontrol zot prop medikaman, me mete sa prinsip-la an pratik atraves chimie produit reyel. Swa ou dan Port Louis ki bezwen soulaz fonksyonel zour san diminisyon, oubyin dan Flic en Flac ki rod plenn force terapeutik pou douler aswar/purir, en produi adapte ou bezwen.

Prodiksion San Solve: Sekurite primordial pou Moris

RSO nou pa enn produi ekstraksyon dan sans tradisionel. Li enn melanj formule kanabinoid distillat ek izola individyel konbine a proporsyon spesifik dan environman kontrole. Pa naphtha. Pa alcool isopropyl. Pa butane. Okenn solve ekstraksyon pa prezan dan produi final.

Sa lapproche elimin risk rezidu solve ki se ene parmi preokipasyon sekirite pli siyifikatif ar prodiksion RSO tradisionel, kuma diskite dan seksyon Rick Simpson.

Produit-la servi lwil MCT organik (triglycerid mwayen chenn) kuma baz transport. Lwil MCT se ene lipide kalite aliman ki fasilite absorpsyon kannabinoid atrave tisi sublingual ek donn ene profil gout neut — ene amelyorasyon siyifikatif konpare konsistans goudron ek fotman rezidu solve RSO tradisionel.

Test lab ters parte kouvi puissance kannabinoid, profil terpene, ek panel sekirite incliw pestisid, metal lour, solve rezidu, ek kontaminant mikrobien. Certificates of Analysis (COA) disponib sou demann ek aksesib atrave sitweb nou.

Sa sa vinn dir pou Moris: Sekirite produi se iniversal. Dan Moris, kot bann ajans proteksyon konsomater travay pou asir kalite produi, lapproche test nou aliy avek bann standar internasyonal. Kan ou kmande depi Moris, ou recev ene produi teste lab avek dokimantasyon konpli — pa ene ekstrak marche noir kalite inkonnu.

De Formats Produit Pou Bezwen Morisien

RSO Lwil Sublingual — $129.99

• Boutey 30 mL (1 fl oz)
• Total kannabinoid 16,590 mg (553 mg par mL)
• Sept kannabinoid: CBD 4,500 mg, CBG 3,000 mg, delta-8 THC 6,000 mg, THCa 1,500 mg, delta-9 THC 90 mg, CBN 750 mg, CBC 750 mg
• Terpene vivan a 5%: limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene
• Baz lwil MCT organik
• Seringue gradue pou doz presiz dan enkreman 0.1 mL
• Debut efet: 15 a 45 minit (absorpsyon sublingual)
• Pik efet: 1 a 2 er
• Dire: 4 a 6 er
• Biodisponibilite: 13 a 19 pousan
• Apepres 40 a 60 doz par boutey selon grosse serve

Perfekt pou Morisien ki bezwen: Soulaz sustine pandant zour ou aswar, kontrol presiz doz, ek flexibilite pou chwazi itilizasyon psikoaktif oubyin non-psikoaktif.

Kartouche RSO Vape — $49.99

• Kartouche 1 gram
• Total kannabinoid 900 mg+
• Mem ratio six-kannabinoid ki formil sublingual (THCa otodekarbe a temperati vape)
• Terpene vivan 5%+
• Konpatibilite batri 510-thread (mache ar bann batri vape standar disponib dan Moris)
• Debut efet: 1 a 2 minit (fason delivrans kannabinoid pli rapid)
• Pik efet: 10 a 15 minit
• Dire: 2 a 4 er
• Biodisponibilite: 10 a 35 pousan
• Dekarboksilasyon otomatik THCa a temperati vape (400 a 450°F)

Perfekt pou Morisien ki bezwen: Soulaz rapid pou douler akut, nawze, oubyin atak panik. Format vape discrete ek portable, ideal pou Morisien ki travay dan ospitalite oubyin touris ki bezwen zesyon imedyat sintom.

Kan Servi Sak Format dan Moris

Ka servi	Format rekomannde	Rasyon
Soulaz rapid (douler akut, nawze, panik)	Vape	Debut 1-2 minit
Soulaz sustine (douler kronik, purir)	Sublingual	Dire 4-6 er
Biodisponibilite maximal	Sublingual	Absorpsyon 13-19%
Portabilite ek discretion	Vape	Konpakt, pa bezwen mezir
Kontrol presiz doz	Sublingual	Seringue gradue dan enkreman 0.1 mL
Itilizasyon zour non-psikoaktif	Sublingual (brut, okenn choz)	THCa res inaktif, zero diminisyon
Aswar psikoaktif	Sublingual (dekarb) oubyin Vape	THCa aktive + delta-8 THC

Konparasyon Konpetitif: Poukoi OilWell pou Moris?

OilWell RSO vs RSO Illegal Tradisionel (Sa Ou Kapav Trouve dan Moris)

Si ou dan Moris ki pe rod RSO atrave kanal informel, ou kapav kontra ek RSO tradisionel fer ar naphtha oubyin alcool isopropyl. Sa ou bizin kone:

Dimenzyon	RSO Illegal Tradisionel	OilWell RSO
Sekirite	Kapav kontni naphpta rezidu (benzene, toluene)	San solve, teste ters parte
Standarize	Okenn — sak lot diferan	Presiz 553 mg/mL, verifie lab
Kannabinoid	Konsetrasyon THC inkonnu (60-90% estim)	Sept kannabinoid definis a ratio egzak
Kontenu terpene	Detrir par choz	5% terpene vivan avek profil terpene-seet
Risk legal	Substance Schedule I (illegal dan Moris)	Derive sorgaz, konform Farm Bill pou expor
Presizyon doz	Devinaz ar serinnz	Seringue gradue, enkreman 0.1 mL
Disponibilite	Marche noir, non-konstan	Expor legal Moris avek dokimantasyon konpli

OilWell RSO vs Lwil CBD-Seulman Disponib dan Moris

Buku magazin byennet Moris vann lwil CBD-seulman. Kouman OilWell difer:

Dimenzyon	Lwil CBD Tipik (mache Moris)	OilWell RSO
Total kannabinoid	500-1,000 mg	16,590 mg (16 fwa plis)
Divesite kannabinoid	Tipikman CBD selman	7 kannabinoid + 7 terpene
Opsyon psikoaktif	Non	Wi — via dekarboksilasyon THCa
Fors klinik	Siplemant byennet	Formilasyon fors klinik
Baz evidans	Limite rechech CBD	Profil evidans multi-kannabinoid
Pri par mg	Souvan pli ser	$129.99 pou 16,590 mg = $0.0078 par mg

Konteks Itilizasyon Spesifik Kondisyon pou Moris

Avetisman enportan: Bann konteks itilizasyon swivan finn enforme par rechech kannabinoid site dan seksyon KONESANS JENERAL ek par nou rasyon formil. Sa pa preskripsyon medikal, pa protokole aprouve FDA, ek pa swasan pou swen medikal profesyonel. Sa bann produi-la pa finn evalwe par Food and Drug Administration ek pa entansione pou diagnoz, tret, geri, oubyin evit nenport maladi. Touletan konsilte enn founise lasante kalifie avan servi bann produi kannabinoid, sitou si ou ena ene kondisyon medikal, pran medikaman, ansemn oubyin alakte, oubyin ena nenport preokipasion lasante. Pa operate vehik oubyin masinn pandan ki anfloans kannabinoid psikoaktif.

Nawze Relasyon Kemoterapi ek Sipor Appeti (Pou Bann Malad Kanse Moris)

• Avan chemo: 0.5 a 1.0 mL sublingual apepres 1 er avan tretman
• Nawze akut: 2 a 3 puff vape pou soulaz imedyat (debut 1-2 minit)
• Apre chemo: 0.5 mL sublingual chak 6 er selon bezwen
• Sipor purir pandan tretman: 1.0 a 2.0 mL sublingual avan dodo (delivre 25 a 50 mg CBN)
• Konteks evidans: evidans antiemetik delta-8 THC [9], evidans nawze delta-9 THC [1][13], tampon anxiolytik CBD [3]

Pou bann Morisien pe fer chemo dan SSR National Hospital oubyin klinik onkologi prive: Nou konpran sa se ene peryod extraordinerman difisil. Nou lapproche multi-kannabinoid sik nawze depi plizir ang. Format vape donn soulaz imedyat kan nawze vwap enprer. Format sublingual donn sipor sustine. Touletan kordinasyon ar ou onkolog.

Douler Kronik (Fibromyalgie, Artrit, Neuropati) — Komen Travayer Agricole Moris

• Zour: 0.3 a 0.5 mL sublingual brut — donn ekspozisyon kannabinoid anti-inflammatwar san diminisyon psikoaktif
• Aswar: 0.5 a 1.0 mL sublingual dekarb — konbine soulaz douler ek sipor purir CBN
• Douler akut: Vape selon bezwen pou debut rapid
• Konteks evidans: evidans douler CBD [4], evidans douler delta-9 THC [13], agonism CB2 bata-karyophyllene [24], inhibit COX-2 THCa [12]

Pou bann travayer kann Morisien, travayer konstriksyon, ek lezot travay fizikman epe: Douler kronik repandu. Bann medikaman douler tradisionel ena limit ek risk. Nou opsyon sublingual brut les ou travay san diminisyon pandan ki ou geri inflamasyon. Vape donn souliz apre ene long zour. Terpene karyophyllene spesifikman sik respete CB2 imike dan douler inflamatoire.

Sipor Purir — Pou Bann Soferer Ensonmni Moris

• Avan dodo: 1.0 a 2.0 mL sublingual
• A 2.0 mL, sa delivre 50 mg CBN — nivo doz investigate dan literati purir 2024
• A 1.0 mL, sa delivre 25 mg CBN — anler swiy sey 20 mg ki asosye ek reduksyon deranj purir dan rechech pibliye
• Konteks evidans: evidans purir CBN [16][17], literati revi kannasil ek purir

Pou bann Morisien ki pe gouman ar ensonmni dan klima imid kotier oubyin environman urban stressant: Disorder purir komen. Nou kontenu CBN specifike formile a nivo siporter par rechech. Konbine ar terpene myrcene ek linalool, sa kreye profil sipor purir ki depase bann apwoche kannabinoid-seulman.

Anksiyete ek Stress — Pou Bann Profesyonel Moris lor Pression Hau

• Soulaz fonksyonel zour: 0.3 mL sublingual brut — CBD ek CBG adress bann voie anksiyete san diminisyon psikoaktif
• Aswar: 1.0 mL sublingual — profil kannabinoid konpli inkliz CBN pou arkitektir purir
• Konteks evidans: evidans anksiyete CBD [3], farmakolozi CBG [7][8], evidans entourage-effect limonene [20]

Pou bann Morisien dan finans, zesion touris, oubyin nenport profesyon lor stress: Anksiyete kapav desabilitan. Nou opsyon sublingual brut les ou res konpletman fonksyonel travay pandan ki ou geri stress biokimik. Terpene limonene donn propiyete sipor lanmood san sedasyon.

Prinsip Titrasyon Jeneral pou Morisien

Komanse ba, ale lanteman. Komanse avek 0.25 a 0.5 mL sublingual ek evalye efet pandan 2 a 3 er avan ogmant. Repons individyel varie selon pwa ko, metabolis, tolerans, medikaman simultane, ek lezot fakté. Bann kliyan Morisien bizin partikilyerman atansion ar hidratasyon ek nitrision, parski kannabinoid kapav afekte apeti ek metabolis.

Portfolio Produit OilWell Pli Lare

Anplas RSO, nou prodwi ene gamme produi kannabinoid, sak develop depi konesans formulatin ki Colin finn bati pandan disan vwayaz Bentley ek so prop eksperyans avek PTSD ek siyomman benzo.

Asshole Peach — Nou plis popila produi. Asshole Peach se ene eksperyans formule avek swen ki design pou donn ene sansasyon ewforik, dirab. Li partikilyerman favorizer par veteran pou kapasite soulaz douler ek sintom PTSD san tro aggressif.

Peace Gummies — Devlope diratek depi experyans pesonel Colin avek PTSD ek adiksyon benzodiazepine. Peace Gummies inn ed li kite Xanax sans rap. Formil-la disponib osi dan form vape pou soulaz rapid — Colin itiliz pesonelman vape pou geri so ensonmni ek PTSD sever an kouran. Sa pa konesans teorik. Colin finn viv sa ki bann malad RSO viv.

Kreyasyon koutom — Nou ofer produi koutom, fabrike selon bezwen spesifik bann kliyan individyel. Swa ratio kannabinoid spesifik, format delivrans partikilye, oubyin formulasyon pou sikonstans lasante inik, nou designe produi sible sou demann. Sa inkliz formulasion pou vegan, dibetik, ek sa ki genyen bezwen dietetik oubyin lasante spesifik.

Sa sa vinn dir pou Moris: Si ou genyen bezwen dietetik spesifik (halal, kosher, vegan), kondisyon lasante, oubyin bizwen ratio kannabinoid koutom ki pa disponib dan nou bann produi standar, nou kapav formulate pou ou. Popilation divese Moris ena bezwen divese — nou satisfi sa.

Livrezon ek Aksesibilite Global Moris

Expor Internasyonal Moris

OilWell expor internasyonal ek finn deja livre plizir peyi atrave plizir kontinan. Kad legal THCa fer sa posib: parski produi-la konten mwins ki 0.3% delta-9 THC akoz lavant, li korespand definisyon produi derive sorgaz selon Farm Bill 2018 ek exporable dan jiridiksiyon avek lwa sorgaz konpatib.

Pou bann kliyan Morisien:

• Tou paket internasyonal inkliz dokimantasyon konpli, Certificates of Analysis (COAs), ek resi pou douane
• Frè livrezon minimal plat aplik; frè internasyonal ekseesif facture kliyan
• OU responsab pou verifie legalite dan Moris ek aksepte tout risk douane ek legal
• Kontakte nou: (832) 416-2816 oubyin [email protected]

Estime livrezon Moris: 7-14 zour ouvrab via USPS Priority Mail International oubyin FedEx International. Nou rekomande FedEx pou klirens douane pli rapid dan Moris.

Siyifikasyon pou Moris

Rick Simpson pa ti kapav expor so lwil nenpart — li te Schedule I, illegal pou prodwi, poses, oubyin transport. En malad kanse oubyin souferer douler kronik Morisien kapav zordi potensielman aksede mem formil RSO multi-kannabinoid fors klinik ki enn rezidan Houston recev par livrezon mem zour. Nou finn bati ene produi kapav trase frontier legalman — konplete ene eleman vizyon Rick Simpson ki interdiksion finn fer imposib pandan so lavi latrayona.

Teknoloji PANDEM1C SEO OilWell — ene sistem propriyete avek 14 milyon sikonstans geopolitik dan so baz done ek plis ki 300 model AI — pousse vizibilite rechech organik atrave six kontinan, ki fer nou bann produi dekouvrab pou bann malad Morisien ki rod RSO an Angle oubyin Franse.

Kouma Bann Formil OilWell Konekte ar Evidans

Sak kannabinoid dan nou formil — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, ek CBC — ena so prop profil evidans dan seksyon KONESANS JENERAL. Sak terpene — limonene, myrcene, caryophyllene, pinene, linalool, humulene, ek terpinolene — finn kouvi avek evidans preklinik ek nivo revi.

Bann formil pibliye dan sa dokiman-la ankr a rezime par-konpound. Nou pa ekzanpt noumenm mem bann standar evidans ki aplik dan domain pli lare. Kot nou RSO guide page fer reklamasyon rechech spesifik lor kannabinoid individyel oubyin terpene, sa dokiman-la bay konteks evalyasyon sous — mem bann sitasyon revise par koly, mem evalyasyon nivo evidans, ek mem kad entepretasyon pridan.

Nou pozisyon — kuma deklare ABC13 dan 2019 — se ki dimoun merite pli bon versyon linformasyon posib pou kapav donn li enn sel akey e deside zotmem si li bon oubyin move pou zot. Sa dokiman-la se fondasyon rechech pou sa pozisyon-la.

KONESANS JENERAL: Lasians Deriye Sak Konpound

Metod Rechech ek Lestaz Evidans

Seksyon-la pran priorite bann sous dan lod swivan: evidans klinik imen, revi sistematik ek meta-analiz, rezime NIH ek lezot enstitisyon, apre literati mekanis ou preklinik leki evidans imen ra. Sa lestage-la enportan isi parski baz evidans pa distribiye iniformeman. Parmi bann konpound liste, CBD ek delta-9 THC ena literati imen la pli for; delta-8 THC, THCa, CBG, CBN, CBC, ek laplipar terpene plis depann lor revi, travay animal, farmakoloji in vitro, oubyin literati translasyoner boner [1]-[29].

Sa sa vinn dir pou Moris: Nou pa kasie ar reklamasyon vag. Nou dir ou ekzak nivo evidans ki siporte sak konpound. Pou bann kliyan Morisien ki vale rigor siantifik, sa transparans-la essensiel.

Baz Enstitisyonel depi NIH ek Sous Lye

• NCCIH deklare ki evidans kannabinoid la pli for etabli se pou sertenn epilepsi rar, nawze ek vomisman kemoterapi, ek indikasyon appeti oubyin pertwa asosie ar HIV/AIDS. Li note osi evidans selman modelman pou douler kronik ek sintom sclerose multiple, avek boukou lezot itilizasyon soi-di-sot dan rechech prelimine [1].
• NCCIH met lanzami ki FDA pa aprouve plant kannabis li-mem pou itilizasyon medikal, byenke CBD purifie ek drg sintetik THC finn ganny spesifik apwobasyon [1].
• Preokipasion sekirite repete inkliz diminisyon, risk aksidan vehik, disorder itiliz kannabis, preokipasion ansemn, exposisyon pediatrik aksidantel, kontaminasyon oubyin inekzaktitid etiquetaz, ek preokipasion blezon poumon vape THC [1].
• NCCIH avetisman espesifik ki produi CBD over-the-counter kapav difer ar zot etiquet ek ki CBD li-mem finn asosie avek diminisyon alert, efet gasri, efet relier foie, ek interaksyon drg [1].

Sa sa vinn dir pou Moris: Sa bann pozisyon enstitisyonel-la enportan. Dan Moris, kot bann founise lasante kapav mwins konn kannabinoid, referans pozisyon NIH donn kredibilite ek konteks sekirite.

Profil Kannabinoid

CBD

• Profil evidans: Evidans imen la pli for dan nou formil, sitou pou disorder konvulsion [1][2].
• Anxiyete: Revi sistematik 2024 finn trouv sinyal anxiolytik siyifikativ me stress echantiyon klinik limite [3].
• Douler: Revi 2024 finn konklu promette me eterojenn, ki limite reklamasyon analgesik lare [4].
• Purir: Revi 2023 finn trouv literati methodologikman feb [5].
• Sekirite: Revi 2023 finn trouv sinyal real pou elevasyon enzim foie ek posib blezon foie indik par drg, espesyelman relevant pou produi oral konsetre [6]. NCCIH monte diarse, somnolans, modifye appeti, efet lanmood, anomalie fonksyon foie, ek interaksyon drg [1].
• Keksoz final pou Moris: CBD se kannabinoid non-intoksikan plis devlope evidansman, me evidans for konsetre dan indikasyon spesifik olye revendikasyon lare byennet.

CBG

• Profil evidans: Plis revi nivo ek preklinik; evidans imen res sparzim [7][8].
• Farmakolozi: CBG se prekrsor biosintetik pou boukou kannabinoid major, avek interaksyon atrave respete kannabinoid, alpha-2 adrenocepteur, ek siyalizasyon 5-HT1A [7].
• Voie potansiel: Disorder neurologik, maladi bowel inflammatoire, aktivite antibakteriyen — primerman ipotez dirij par farmakolozi [7][8].
• Pridans: CBG deza vann komersyalman pandan ke baz evidans res mince [7].
• Keksoz final pou Moris: CBG se ene kannabinoid mineur promette avek validasyon klinik limite. Reklamasyon bizin rezerve.

Delta-8 THC

• Profil evidans: Farmakologikman relevant, psikoaktif, bouku mwins karakterize klinikman ki delta-9 THC [9]-[11].
• Farmakolozi komparatif: Revi 2022 finn konklu delta-8 ek delta-9 ena konportman lareman simila, me delta-8 apar mwins puissant akoz pli feb afinite CB1 [9].
• Lasante piblik: Revi 2023 finn trouv baz evidence domine par etid animal, chemis produi, ek preokipasion lasante piblik olye for letid imen [10]. Rapo konsekans defavorab note [10].
• Fabrikasyon: Linté komersyal lie ar pli gran stabilité ek sintez pli fasil konpare ar niveau plant natirel ra [11].
• Keksoz final pou Moris: Delta-8 THC se ene analog THC psikoaktif avek aktivite farmakolojik real, karakterizasyon sekirite/efikase inplen imen, ek enkerte konseyon kalite fabrikasyon. Traite li seriyman.

THCa

• Profil evidans: Enportan chimikman ek pou formulasyon, me evidans therapeutic imen direk feb [12].
• Ki li ye: Prekrsor asidik THC. Dekarboksil an THC pandan choz ek kapav sanze avek letan pandan stokaz [12].
• Psikoaktivite: THCa li-mem pa prodwi efet psikoaktif THC — me selman si li res dan form asidik ek pa dekarboksil [12].
• Status rechech: Literati in vitro ek roz finn suzere posiblite anti-inflammatwar, imunomodilater, neuroprotektif, ek antineoplastik, me pa rezilta imen etabli [12].
• Keksoz final pou Moris: THCa mwens konpran kom prekrsir molekil ki lintpretasyon depann lareman lor rout, temperati, proces, ek stokaz. Nenport reklamasyon bizin konte posiblite konversyon an THC [12].

Delta-9 THC

• Profil evidans: Evidans imen la pli for kannabinoid psikoaktif, me osi liability efet defavorab la pli kler [1][13]-[15].
• Sipote enstitisyonelman: NCCIH idantifie relevance pou nawze kemoterapi, appeti VIH/SIDA, sertenn rezilta MS ek douler [1].
• Evidans douler: Revi sistematik 2022 finn trouv ki produi THC-lot kapav donn benefis douler termen kout me ogmantasyon vertiz, sedasyon, nawze, ek abandonn [13].
• Farmakokinetik: THC inhale: efet dan segonn a minit, pik 15-30 minit, diminisyon plizier er. THC oral: debut pli tar, pik pli tar, dire pli long [14].
• Risk lasante mantal: Revi sistematik 2025 finn trouv asosiyasyon defavorab konsistan avek psykos/schizophrenia ek disorder itiliz kannabis, ek sinyal alarman pou anxiyete ek depressyon [15].
• Sekirite pli lare: Anksiyete/panik a doz o, tachycardia, sanzman presyon disan, dependans, siy withdrawal, preokipasion ansemn, exposisyon pediatrik aksidantel, blezon poumon vape [1][14][15].
• Keksoz final pou Moris: Delta-9 THC ena relevance therapeutic legitim me transport liability intoxikasyon, psikiatrik, ek sekirite lie doz la pli kler. Servi ak pridans ek gidans medikal.

CBN

• Profil evidans: Evidans imen feb; marketing davans done [12][16][17].
• Marketing vs. realite: Repitasyon purir, me revi 2021 finn analiz 99 rezime letid imen ek pa finn trouv okenn letid klinik servi kestyoner purir valide oubyin polysomnographie pou sibstansye reklamasyon purir for [16].
• Literati purir 2024: Revi misa jour finn konklu ki rechech purir global kannabinoid touzour pa alaychel ekhel itilizasyon realite [17].
• Konteks chimik: THC kapav degrade ver CBN dan sertenn kondisyon [12].
• Keksoz final pou Moris: CBN se leksamp la pli kler kot reputasyon kiltirel pli for ki evidans klinik [16][17].

CBC

• Profil evidans: Emerzan, intrigant, majorite preklinik oubyin base revi [18][19].
• Farmakolozi: Revi 2024 argumente ki CBC ena farmakodinamik, farmakokinetik, ek konportman respete distink, met laksan antinociceptif, antibakteriyen, ek anti-konvulsion — evidans imen bouku mince [18].
• Literati pli vye: Efet anti-inflammatwar, reduksyon hypemobilite intesten, analgesie model roz, posib relevance neurobiolozik/antiproliferatif — pa evidans fas malad [19].
• Pridans sekirite: Produit CBC over-the-counter deza vann malgre evidans klinik limite etablissant efikasite oubyin sekirite [18].
• Keksoz final pou Moris: CBC se ene kannabinoid mineur siantifikman kredib merit pli rechech, pa deza aktif klinik valide [18][19].

Profil Terpene

Limonene

• Profil evidans: Majorite revi ek preklinik [20]-[22].
• Aktivite potansiel: Revi 2021 dekri efet antioxydant, anti-inflammatwar, kardioprotektif, gastroprotektif, imunomodilater — plis sors non-humain/kannabis [21].
• Avetisman sekirite: Bwa oksidasyon limonene (hydroperoxide) se alerjan kontak klinikman relevant [22].
• Keksoz final pou Moris: Bioaktif biolozikman, me reklamasyon therapeutic spesifik a kannabis bizin rezerve.

Myrcene

• Profil evidans: Plis preklinik, evidans imen tres limite [20][23].
• Rezime rechech: Revi 2021 dekri propiyete anxiolytik, antioxydant, anti-inflammatwar, analgesik, me dekler eksplisitman ki etid imen manke [23].
• Pridans entepretasyon: Souvan invike kuma sedatif prouve ki spikye couch-lock, me sa se reklamasyon pli for ki evidans imen siporte [20][23].
• Keksoz final pou Moris: Terpene bioaktif plozib, me reklamasyon klinik spesifik molekil konsern lanmood, douler, oubyin sedasyon res lwen devan prouv definitive imen.

Caryophyllene

• Profil evidans: Parmi pli interesan mekanistikman akoz relevance sistem kannabinoid, me touzour plis preklinik [24].
• Poukoi li difer: Revi 2021 dekri beta-caryophyllene kuma agonist respete CB2 selectif — inusite ek farmakolozikman partikilyerman relevant [24].
• Tem rechech: Anti-inflammatwar, imunomodilater, antioxydant, neuroprotektif, gastroprotektif — konfirmasyon klinik imen limite [24].
• Keksoz final pou Moris: Kandida pli for pou terpene avek siyifikasyon sistem kannabinoid, me pa dwa dekri kuma prouve klinik.

Pinene

• Profil evidans: Literati preklinik promette, konfirmasyon imen feb [20][25].
• Kad lasante sek: Revi 2021 finn trouv sinyal antioxydant, anti-inflammatwar, neuroprotektif ki justify rechech futur, me stress mank letid klinik byen design [25].
• Pridans entepretasyon: Revandikasyon ki pinene amelyore memwar, atrasifye latansion, oubyin kontrapese efet kognitif THC rest ipotez olye fakta etabli [20][25].
• Keksoz final pou Moris: Merit latansion siantifik, me reklamasyon for konsern kognisyon bizin prezante kuma eksplorater.

Linalool

• Profil evidans: Lintérê preklinik sostansiel, konfirmasyon klinik direk limite [20][22][25][26].
• Rezime rechech: Souvan diskite an relasyon ar stress, lanmood, farmakolozi lasante sek. Revi lasante sek 2021 finn trouv ase sinyal preklinik pou kontinie lenket pendant ki stress mank robust letid imen [25].
• Literati siplemantera: Literati revi diskite mekanis posib antidepreser, me res translasyonel olye definitif [26].
• Avetisman sekirite: Hydroperoxide linalool okside rekonesi kuma alerjan [22].
• Keksoz final pou Moris: Terpene bioaktif siantifikman kredib, me evidans aktiel siporte fraz prudan.

Humulene

• Profil evidans: Translasyonelman interesan, me boner [20][27].
• Rezim revi skoping: Revi 2024 finn analiz 340 article, trouv evidans lare anti-inflammatwar preklinik, avek travay roz ki suzere propiyete kannabimimetik via CB1 ek voie adenosine A2a [27].
• Pridans entepretasyon: Bann trouvay valab pou jenere ipotez, me pa etabli efikasite imen konsistan [27].
• Keksoz final pou Moris: En terpene pli interesan pou rechech, me touzour lwen etabli klinikman.

Terpinolene

• Profil evidans: En terpene pli mwins klinikman karakterize [20][28].
• Rezim revi sistematik: Revi 2021 finn analiz 2,449 dosye, inkliz 57 letid, konklu ki terpinolene ena gam efet biolozik reporte me baz evidans domine par etid in silico, in vitro, ek animal [28].
• Pridans entepretasyon: Mem revi entourage recent kannabis definir benefis terpene kuma eksplorater, olye efet klinik spesifik konpound establi [20].
• Keksoz final pou Moris: Biointeresan, me parmi terpene liste, rez particilyerman sous-developper klinikman [20][28].

Limit Rechech ek Entepretasyon

• Baz evidans anpak inifom. CBD ek delta-9 THC sipporte deklaration plis detaye fas malad; reste bizin pli pridans [1]-[29].
• Done ekstrait kann-global, done molekul purifie, done kannabinoid semisyntetik, ek done terpene-seulman pa entervanjib. Lere komen se les evidans enn kategori ranplas pou lezot.
• Kannabinoid mineur ek terpene interesan komersyalman presizeman akoz mal-explore, me sa vle osi dir reklamasyon souvan devlope.
• Kalite produi enportan kuma molekil identite. Lerekzaktitid etiquet, kontaminasyon, produi secondaire sintez, variabilite doz, ek farmakokinetik dependan voie tou afekt materyelman lintepretasyon [1][10][11][14].
• Pour THCa, chimie se destinasyon: stokaz ek choz kapav sanze profil ekspozisyon aktiel par konversyon kannabinoid asidik an kannabinoid neutel kuma THC [12].

Bann Exajerasyon Komen Pou Evit (Partikilyerman Enportan Pou Bann Kliyan Morisien)

• Exajerasyon: CBN se kannabinoid prouve purir klinikman.
  Plis presi: Evidans purir pou CNB res feb, san baz solid letid valide [16][17].
• Exajerasyon: Myrcene se sedatif prouve imen ki spikye couch-lock.
  Plis presi: Myrcene ena bioactivite preklinik plozib, me purf direct imen limite [20][23].
• Exajerasyon: Terpene ena efet entourage prouve kotes malad.
  Plis presi: Ipotez entourage influan ek merit letid, me purf robust klinik res limite [20][29].
• Exajerasyon: THCa touletan nonpsikoaktif.
  Plis presi: THCa-mem pa THC, me choz ek proces kapav konverti THCa an THC [12].
• Exajerasyon: Delta-8 THC an sekirite parski derive sorgaz.
  Plis presi: Delta-8 THC psikoaktif, farmakolozikman pre ar delta-9 THC, ek souvent mele avek preokipasyon fabrikasyon ek test [9]-[11].

Bann Lekon Pratik Pou Nou Bann Kliyan Morisien

• Aktif plis developpe evidansman: CBD ek delta-9 THC.
• Delta-8 THC pa trivial; se psikoaktif avek karakterizasyon sekirite/efikasite mwins robust ki delta-9 THC.
• THCa sanze siyifikativman avek proces; pa dwa lintprete mem fason dan format brut, manze doucement, ek choz.
• CBG, CBN, ek CBC siantifikman kredib me klinikman imature konpare ar CBD ek THC.
• Terpene liste probableman trè relevant pou arom, gout, ek posib aktivite biolozik, me reklamasyon therapeutic spesifik imen bizin fer avek pridans ek selman kot dirèkteman siporter.

Formil RSO Lwil Sublingual (Avek Source Owver)

Kannabinoid	Kantite
CBD	4,500 mg
CBG	3,000 mg
Delta-8 THC	6,000 mg
THCa	1,500 mg
Delta-9 THC	90 mg
CBN	750 mg
CBC	750 mg
Total Kannabinoid	16,590 mg

• Terpene Vivan: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: Boutey 30 mL
• Kannabinoid aktif par mL: 553 mg
• Transporteur: Lwil MCT organik
• Pri: $129.99 USD

Pou bann fabyek Morisien: Si ou pa kapav pe $129.99 oubyin frè livrezon Moris proibitif, sa se ou resèt. Sours distillat ek izola kannabinoid individyel depi founise kredib (asir ki zot expor Moris), melange dan ratio egzak servi lwil MCT organik kuma transporteur. Sa se formil ki finn pran dis an pou parfe. Li pou ou servi.

Formil Kartouche RSO Vape (Avek Source Owver)

Kannabinoid	Pourcentaz
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Terpene Vivan: 5%+
• Format: Kartouche 1 Gram
• Ros: 510 universal (mache ar bann batri vape standar dan Moris)
• Pri: $49.99 USD

Pou bann fabyek Morisien: Sa formil base sou pourcentaz-la designe pou remplissaz kartouche vape. Bezwen ekipeman profesyonel pou preparasyon an sekirite. Nou rekomande aste kartouche fini sof si ou ekperians ekstraksion/formulasyon.

Profil Terpene (De De Produi)

• Limonene: Kler sitruse, sipor lanmood
• Myrcene: Herbace, propiyete kalman
• Caryophyllene: Piman/eksite, agonist CB2 pou inflamasyon
• Pinene: Bwa freyer, amelyore klarite
• Linalool: Fleuri (lavande), kalman
• Humulene: Bwa/terreux, anti-inflammatwar
• Terpinolene: Bwa/frite, efet konpleks

Gout ek odor: Profil konbine form riche, a koub, ek natirel — nanye tank gou kon goudron akoz rezidu solve RSO tradisionel. Pou palat Morisien ki abitie ar profil eksite konpleks dan kizin, sa melanj terpene-la sanze familier ek agree sensorielman.

Resèt Golden Paste CBD Bentley (Formil Owver Originil)

Nou finn pibliye sa resèt-la an avan bann formil RSO — formil owver originil ki sov Bentley:

Engra:

• 1/2 tas poud kurkuma organik
• 1 tas dilo
• 1/3 tas lwil kok (non-rafin, organik)
• 1 a 2 kiyer piman nwar moulin fre (enportan pou absorpsyon)
• Lwil CBD (doz depend grander lezanim ek bezwen; konsilte veterinere)

Enstriksyon:

1. Melange kurkuma ek dilo dan kaserol, remoue a fe dous ziska forme pate epes (7-10 minit). Ajoute plis dilo si tro epes.
2. Ajoute lwil kok ek piman. Remoue ziska melanj konplete.
3. Les refwad ek gard refrigerateur pandan jiska 2 semenn.
4. Ajoute ti kantite lwil CBD pate avan donn lezanim, ajuste doz selon pwa ek besyen lasante. Komanse ba ek ogmant gradiel.
5. Melange ti kantite ar manje lezanim enn ou de fwa chak zour. Swazye pou sanzman. Konsilte veterinere si preokip.

Sa sa vinn dir pou Moris: Si ou enn pwopriyetier lezanim Morisien ki fer fas ene kriz parey ar ou bann lesyen oubyin kat, sa resèt-la se pou ou. Li gratis, teste, ek ti mars lor Bentley kan medsin veterinery ti dir pa ena plis espoir. Bann lesyen pa reponn placebo — sa real.

Kesyon Komen Pou Bann Kliyan Morisien

K: Li legal pou expor RSO Moris?
R: Nou expor bann produi derive sorgaz kontenant mwins ki 0.3% delta-9 THC, ki legal pou expor selon Farm Bill LetaZini. Ou bizin verifye ki lwa Moris permet import ek posesyon sa bann produi-la. Nou bay dokimantasyon konpli pou douane.

K: Est-ce mo pou gagne lor ar lwil sublingual?
R: Selman si ou deside. Dan so form brut, gros kontenu THCa non-psikoaktif. Si ou dekarboksil pa choz, li vinn tre psikoaktif. Ou kontrol sa.

K: Komin letan livrezon Moris pran?
R: Tipikman 7-14 zour ouvrab via USPS Priority Mail International oubyin FedEx International. FedEx an jeneral klire douane Moris pli vit.

K: Est-ce mo kapav servi sa pandan mo travay dan sektor touris Moris?
R: Wi, servi form sublingual brut (non-dekarboksilize) pandan le tan travay pou zero diminisyon. Vape oubyin lwil dekarb bizin servi selman kan diminisyon acceptable (ex., lakaz).

K: Sa ansanm avek mo lot medikaman an sekirite?
R: CBD kapav interakti avek sertenn medikaman, sitou sa metabolize par foie. Konsilte ou dokter oubyin famasien Moris avan konbine avek lot drg.

K: Kouma mo konpran produi-la real ek pa fake?
R: Sak exporasyon inkliz Certificate of Analysis (COA) depi lab ters parte ki montre kontenu kannabinoid egzak. Kodye QR COA verifie online. Dosye medya nou donn verifikasyon independan legitimite nou.

K: Poukwa li ser?
R: Ou recev 16,590 mg kannabinoid total atrave seet konpound, teste lab, avek formils pibliye. Sa 16 fwa plis kannabinoid ki bann lwil CBD tipik. Pri par miligram aktyelman pli bas ki boukou produi disponib dan Moris.

K: Si mo pa kapav pe sa?
R: Formil konpli finn pibliye dan sa guide-la. Si ou kapav sours distillat kannabinoid individyel ki expor Moris, ou kapav fer li zotmem. Sa se promes owver nou.

K: Eski sa geri kanse?
R: Okenn produi finn prouve geri kanse imen. Rechech preklinik sou kannabinoid interesan ek kontinie, me pa konkluan. Servi RSO kom ene apwoche konplemantèr ar tretman medikal prouv, pa kuma ramplasman.

K: Est-ce mo kapav vwayaze dan Moris avek sa produi?
R: Dan Moris, ou somit a lwa Moris. Gard produi dan so emballage originel avek COA. Pa pote kartouche vape dan avyon akoz restriksyon batri. Lwil sublingual pratik pou vwayaz.

Avetisman Sekirite ek Avetisman Legal pou Moris

Egzistans lage: 21+ pou tout produi RSO.

Avetisman FDA: Sa bann produi-la pa finn evalwe par Food and Drug Administration. Zot pa entansione pou diagnoz, tret, geri, oubyin evit nenport maladi. Rezilta individyel kapav varie. Konsilte founise lasante avan servi.

Avetisman sekirite:

• Kapav lakoz somnolans oubyin diminisyon. Pa kondwit vehik oubyin opera masinn pandan ki anfloans kannabinoid psikoaktif.
• Gard lwen bann zanfan ek lezanim domestik.
• Pa servi si ansemn oubyin alakte.
• Konsilte ou dokter si ou ena ene kondisyon medikal oubyin pran medikaman, sitou dan kontekst polifarmasi Moris kot interaksyon drg ene reyal preokipasyon.
• Gard dan le frais, sec, ek lwen solèy dikte. Dan klima tropical Moris, refrigere apre ouver rekomanze.

Responsabilite legal: Bann kliyan Morisien sel responsab pou verifye konformite import, poses, ek itilizasyon ar lwa Moris. OilWell pa asime okenn responsabilite legal pou ou itilizasyon oubyin desizyon dekarboksilasyon. Produit annile kot prohibe par lwa Moris.

Avetisman enportan pou Moris: Pandan ki nou bann produi legal pou export depi U.S., lwa kannabis Moris kapav diferer. Dapre denye misa jour nou, Moris pa finn legalize kannasil rekresyonel, me bann produi derive sorgaz kapav tom anba regleman diferan. Nou konsile dan fas konsilte ene eksper legal Moris oubyin ofisyel douane avan kmande.

Kouma Kmande RSO dan Moris

Etap 1: Verifie Status Legal

Konfime ki lwa Moris permet import bann produi kannabinoid derive sorgaz kontenant <0.3% delta-9 THC. Kontakte Douanes Moris si osi.

Etap 2: Chwazi Ou Format

• Lwil Sublingual: Pou soulaz sustine, kontrol presiz doz, itilizasyon zour non-psikoaktif (brut), oubyin aswar psikoaktif (dekarb)
• Kartouche Vape: Pou soulaz rapid, portabilite, sintom akut eclatement

Etap 3: Plase Ou Kmand

Visit OilWellCBD.com ek seleksyone ou produi. Akoz ou peye:

• Rense ou ladres livrezon Moris
• Seleksyone “International Shipping”
• Ajoute nenport enstriksyon douane spesial
• Peman: Nou aksepte kart kredi major ek kriptomonnaie pou kmand internasyonal

Etap 4: Dokimantasyon Douane

Nou automatiqueman inkliz:

• Certificate of Analysis (COA) ki montre kontenu kannabinoid
• Facture avek deskripsyon produi kuma “hemp-derived cannabinoid oil”
• Let konformite Farm Bill
• Kopi lisians Texas DSHS

Etap 5: Swiv Ou Kenvoi

Ou recev lenformasyon swiv par email. Swiv progres atrave douane Moris. Si douane kontakte ou, donn li COA ek dokimantasyon nou finn inkliz.

Etap 6: Receive ek Servi Responsableman

Kan arrive Moris:

• Enspekte pak pou siy douane
• Verifye ki produi korespann COA
• Gard korektman (refrigere apre ouver akoz klima Moris)
• Komanse an ti doz ek titre lanteman
• Konsilte founise lasante Moris

Kontakte nou pou kmand Moris: (832) 416-2816 oubyin [email protected]. Nou finn deza expor Moris ek kapav reponn kestyon douane spesifik.

Lakordatrwa: Poukwa Bann Morisien Kapav Konfyans OilWell

Sept segment ABC13, liswar Bentley, konviksyon pesonel Colin, nou bann formils owver, ek 29 sitasyon revise par koly dan sa dokiman-la tou point ver enn konkliyzon: OilWell bati lor kredibilite merite, pa marketing ashte.

Pou bann kliyan Morisien ki pe evalue si konfyans ene konpagni kannabis base LetaZini:

• Verification medya: Sours nwarz #1 Houston finn evaluate nou pou kat an
• Konformite legal: Konform Farm Bill, lisiansie Texas DSHS
• Transparans: Nou pibliye nou bann formils egzak — okenn segre komersyal
• Sians: Sak reklamasyon lie a rechech revise par koly
• Kominn: ~$35,000 dan produi gratis pou vaksinasyon COVID, etik proactive pandan entrediksion delta-8
• Risk pesonel: Fondateur nou finn viv konsekans kriminalizasyon kannabis

Rekonpans pa kapav ashte — selman ganyen merite. Dan bann kominn serre Moris, reputasyon enportan. Nou reputasyon finn dokumente par jounalis independan, verifie par lab ters parte, ek prouve par bann kliyan ki servi nou bann produi pou geri kondisyon ki medsin konvansionel pa finn kapav resolve.

Refleksyon Final Pou Nou Bann Zanmi Morisien

Nou konn ki rechech RSO dan Moris kapav sanze overwelming. Ou pe pwobableman face defi lasante serye — kanse, douler kronik, PTSD, ensonnmi — ek ou bezwen repons onet, pa lesperans fals. Se sakir nou finn bati OilWell diferan.

Nou pa reklam geri kanse. Nou bay plis formil RSO multi-kannabinoid konple, base evidans, aksesib legal disponib global. Nou pibliye nou bann formils pou ou kapav verifye sak reklamasyon. Nou expor Moris pou ou pa bizwen konte lor produi marche noir kalite inkonnu. Ek nou reponn ou kestyon dirèkteman parski se sa ki nou ta envi si nou dan ou le.

De Houston a Moris: Distans la vast, me bezwen kannasinomedisin onet se menm. Nou la kan ou pare.

ENGLISH

Rick Simpson Oil (RSO) in Mauritius: The Complete Guide by OilWell Cannabis

Welcome, Mauritius. We’re OilWell Cannabis, and we built our reputation in Houston, Texas — one of the most medically advanced and legally complex cannabis markets in America — by refusing to sell hype. We believe Mauritians deserve the same level of honest education, pharmaceutical-grade precision, and legal clarity that we provide to cancer patients, veterans, and chronic pain sufferers across the United States. If you’re searching for RSO in Mauritius, whether you’re in Port Louis, Beau Bassin-Rose Hill, or Curepipe, this guide is for you.

About Rick Simpson and Traditional RSO: The Origin Story Every Mauritian Should Know

Who is Rick Simpson?

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor, scientist, or medical professional — he was a power plant engineer and maintenance worker, a blue-collar tradesman whose path into cannabis began when conventional medicine failed him catastrophically.

In 1997, while working at a hospital in Moncton, Simpson fell from a scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that his doctors couldn’t resolve. The medications they prescribed either failed to help or made his condition worse. When cannabis provided more relief than anything his physicians offered, he asked his doctor to support or prescribe it. The request was refused .

Simpson’s interest in concentrated cannabis oil deepened after he learned about a 1974 study funded by the National Institute of Health and conducted at the Medical College of Virginia, in which THC was reported to slow or shrink tumors in mice. That study — originally intended to demonstrate harm — became a foundational reference point in Simpson’s later advocacy, even though its findings were never replicated in controlled human cancer trials .

The pivotal moment in Simpson’s story came in 2003. He reported that three bumps on his arm were diagnosed by his doctor as basal cell carcinoma. Rather than pursuing conventional treatment, Simpson applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. Important context: No independent medical verification of this outcome has been published, and no biopsy confirmation or clinical follow-up has been documented in any peer-reviewed source. This personal experience became the origin story of Rick Simpson Oil .

What this means for Mauritius: Simpson’s story resonates across cultures because it speaks to a universal human experience — being let down by the medical system and seeking alternatives. In Mauritius, where healthcare is generally strong but specialist wait times can be long and integrative medicine options limited, this story may feel familiar. But understanding Simpson’s background is crucial: he was an advocate, not a medical authority. His evidence was personal testimony, not clinical proof.

The Crusade — Spreading the Oil

After his 2003 experience, Simpson committed himself fully to producing and distributing concentrated cannabis oil. Operating out of his property in Maccan, Nova Scotia, he began making the oil in large quantities and giving it away for free to cancer patients and others in his community. He charged nothing. By his own account, he helped dozens of people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more .

Simpson’s story reached a global audience through the 2005 documentary Run From The Cure, directed by Christian Laurette. The film documented Simpson’s claims, showed testimonials from people he had treated, and framed his work as a grassroots challenge to pharmaceutical and governmental interests. It was distributed freely online and became one of the most widely shared cannabis advocacy films of its era .

Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police raided his property in 2005 and 2009. He was charged with cannabis cultivation, possession, and trafficking. Facing continued legal pressure, Simpson eventually left Canada and relocated to Europe, where he continued his advocacy from abroad .

In 2012, Simpson published Phoenix Tears: The Rick Simpson Story, detailing his personal experience, oil-making process, and philosophical views .

Throughout his public career, Simpson maintained that cannabis oil could cure cancer and many other diseases, and that pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge. He framed his work as fighting institutional corruption .

What this means for Mauritius: The legal risks Simpson faced in Canada mirror what many Mauritians may fear. While Mauritius has not legalized recreational cannabis, hemp-derived products with less than 0.3% delta-9 THC fall under a different legal category. OilWell’s products are Farm Bill compliant and ship internationally with full documentation. This legal clarity is what Simpson never had.

The Traditional RSO Protocol — Simpson’s 60-Gram, 90-Day Regimen

Simpson’s core treatment recommendation was a structured oral protocol designed to deliver 60 grams of concentrated cannabis oil over approximately 90 days. He described this as a cancer treatment protocol, though he also recommended it for numerous other conditions .

Goal

Consume 60 grams of concentrated, high-THC cannabis oil over approximately 90 days. Simpson considered this the minimum amount necessary for a serious cancer treatment course.

Titration Schedule

• Week 1: Begin with a dose the size of half a grain of dry rice — roughly 10 to 15 milligrams of oil — taken three times daily. Total daily intake: approximately 30 to 45 milligrams.
• Weeks 2-5: Double the dose approximately every four days to build THC tolerance gradually. By the end of this period, the target is approximately 1 gram (1,000 milligrams) of oil per day, divided into three doses.
• Weeks 5-12: Maintain the full dose of approximately 1 gram per day, divided into three doses of roughly 333 milligrams each, until the full 60 grams are consumed.

Administration Methods

• Primary — oral: Place the dose directly under the tongue (sublingual) or swallow it. Simpson considered oral ingestion the most important route for systemic absorption.
• Secondary — topical: For skin cancers and external lesions, apply the oil directly to the affected area, cover with a bandage, and change every three to four days. He combined topical application with oral dosing for skin cancers.
• Not recommended as primary — inhalation: Simpson did not recommend smoking or vaporizing the oil as a primary treatment method, though he acknowledged it for immediate symptom relief.

Tolerance and Psychoactive Effects

• Simpson maintained that patients would develop significant tolerance to THC’s psychoactive effects within three to four weeks.
• He considered the euphoric, sedating, or disorienting effects a minor and temporary side effect and urged patients not to let the high discourage them from continuing.
• He recommended initial doses at night or before bed to sleep through the most intense psychoactive effects.
• Simpson also recommended that patients avoid driving or operating machinery during the titration period.

Post-Protocol Maintenance

After completing the full 60-gram course, Simpson recommended a maintenance dose of approximately 1 to 2 grams of oil per month, taken indefinitely.

Important Context for Evaluating This Protocol

This protocol was designed by one person based on his personal experience. It was not developed through clinical trials, dose-finding studies, or formal research. Several critical points apply:

• No controlled trial validation. There are no published randomized controlled trials, cohort studies, or well-documented case series evaluating this specific 60-gram/90-day protocol for any condition.
• Assumes crude, unstandardized material. The 60-gram quantity assumes a single-strain, THC-dominant extract with no standardized potency. Actual THC content varied widely.
• Very high THC exposure. At peak dosing, patients consumed roughly 1 gram of high-THC oil per day. Assuming 60-90% THC content, this translates to approximately 600 to 900 milligrams of delta-9 THC per day — a dose far exceeding anything studied in controlled clinical settings. For context, the FDA-approved synthetic THC drug dronabinol is typically dosed at 2.5 to 20 milligrams per day.
• Real risks at these doses. Consuming 600 to 900 milligrams of THC daily carries serious risks including severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder [1][13][14][15].
• Oncology context. Patients with active cancer are often medically complex. Using unregulated, unstandardized cannabis oil as a primary cancer treatment — potentially in place of proven therapies — introduces harm that extends beyond the oil itself.

What this means for Mauritius: Mauritian cancer patients, chronic pain sufferers, and their caregivers researching RSO online will encounter Simpson’s protocol. They need to understand its historical significance AND its limitations. The doses are far beyond what any clinician would recommend, and the product was never standardized or tested. This is where OilWell’s modern approach becomes essential.

What Is Traditional Rick Simpson Oil — The Product

Traditional RSO refers to the specific type of concentrated cannabis oil Simpson made. It was defined not by lab specifications but by his method.

Source material: High-THC, indica-dominant cannabis strains. No strain standardization — the starting material varied by availability and growing season.

Extraction solvent: Naphtha (a petroleum-based solvent) or 99% isopropyl alcohol. Neither is food-grade. Naphtha may contain benzene, toluene, and other toxic or carcinogenic compounds. Incomplete solvent purging leaves potentially harmful residues.

Extraction process: Plant material was soaked in solvent, filtered, and evaporated in a rice cooker at temperatures sufficient to decarboxylate THCa into THC and destroy most terpenes.

Appearance: Nearly black, thick, tar-like oil with a strong cannabis odor and possible solvent-residual smell.

Cannabinoid profile: THC-dominant (60-90% estimated), fully decarboxylated, with minor cannabinoids at natural ratios — uncontrolled, unmeasured, never lab-verified.

Terpene content: Minimal to none. The combination of solvent extraction and high-heat evaporation stripped terpenes from the final product.

Standardization and testing: None. Every batch was different. No Certificate of Analysis, no cannabinoid quantification, no contaminant screening.

Residual solvent risk: Significant. Without lab testing, it’s impossible to verify complete solvent removal.

What this means for Mauritius: If you’re in Mauritius and see a product labeled “RSO” in a local market or online, it likely bears little resemblance to what Simpson actually made — and that’s not necessarily bad. Modern RSO has evolved substantially. The key is understanding what you’re actually getting: a standardized, tested product or a crude, variable extract.

Simpson’s Claims vs. The Evidence Record

Simpson claimed RSO could cure cancer and many other diseases. He was adamant, consistent, and public about these claims throughout his advocacy career .

What Simpson Was Not

He was not a scientist, physician, pharmacologist, or researcher. He had no formal training in medicine, oncology, pharmacology, or clinical research methodology. He never designed, conducted, funded, or published a clinical trial. He never submitted his results to peer review. His entire evidence base consisted of personal experience, self-reported patient outcomes, and testimonials gathered informally — with no controls, no independent verification, no imaging confirmation, no long-term follow-up, and no blinding.

What The Preclinical Literature Shows

• In vitro studies have demonstrated that THC and CBD can induce apoptosis (programmed cell death), inhibit proliferation, and reduce angiogenesis in certain cancer cell lines .
• Animal model studies have shown some tumor-growth inhibition in mice and rats treated with cannabinoids .
• These findings have generated legitimate scientific interest and ongoing research.

What The Preclinical Literature Does NOT Show

• These findings have not translated into proven human cancer cures. The gap between in vitro or animal results and human clinical outcomes is vast.
• No human clinical trial has demonstrated that RSO or any cannabis oil preparation cures cancer.
• Several small human trials of cannabinoids in cancer contexts (particularly glioblastoma) have been conducted, but they have been exploratory, small, and have not produced the kind of results that would support cancer-cure claims .

Institutional Positions

• U.S. National Cancer Institute (NCI): Acknowledges that cannabinoids have been studied for potential anticancer effects in laboratory and animal models but does not endorse cannabis or cannabis oil as a cancer treatment .
• U.S. Food and Drug Administration (FDA): Has not approved any cannabis plant product for the treatment of cancer. The only FDA-approved cannabinoid-related products are for other specific indications: Epidiolex (CBD) for certain seizure disorders and dronabinol/nabilone (synthetic THC analogues) for chemotherapy-related nausea and AIDS-related wasting [1].
• Health Canada: Has never approved RSO or cannabis oil as a cancer cure.
• NCCIH: Explicitly states that the strongest cannabinoid evidence is for rare epilepsies, chemotherapy-related nausea and vomiting, and appetite-related indications in HIV/AIDS — not cancer cure [1].

What Simpson Got Right

Simpson drew attention to cannabinoids as a serious area of biomedical research at a time when most of the world was ignoring or actively suppressing that conversation. His advocacy helped create the political, cultural, and social conditions for the legal cannabis industry and the cannabinoid research infrastructure that exists today. He was among the first to bring concentrated cannabis oil to widespread public awareness, and the term RSO itself remains the most recognized name for full-spectrum cannabis extract.

What He Overstated

The leap from preclinical signals to cancer cure was not supported by human evidence when Simpson made it, and it is not supported now. Encouraging patients — particularly cancer patients — to rely on RSO as a primary treatment in place of proven oncologic therapies carries genuine harm potential. Delayed or foregone treatment for treatable cancers is a documented concern in the alternative-medicine literature.

What this means for Mauritius: Mauritian cancer patients and their families deserve honesty. The hope that RSO offers is real and powerful, but it must be grounded in evidence, not false promises. RSO should complement medical care, not replace it. If you’re in Mauritius undergoing cancer treatment at SSR National Hospital, Jawaharlal Nehru Hospital, or any private oncology clinic, discuss any cannabinoid use with your oncologist. The science is interesting. The cure claims are not proven.

Traditional RSO vs. Modern Formulated RSO

Dimension	Traditional RSO	OilWell Formulated RSO
Source material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction method	Naphtha or isopropyl alcohol	Modern food-grade ethanol or CO₂ methods
Cannabinoid profile	THC-dominant, uncontrolled	Seven defined cannabinoids at specific ratios
Terpene content	Destroyed by high-heat process	Live terpenes at 5% with defined seven-terpene profile
Standardization	None — every batch different	Lab-tested with specific mg/mL targets
Lab testing	Not available or performed	Full panel testing
Residual solvents	Significant risk with naphtha	Controlled and tested
Dosing precision	Approximate, syringe-based	Measured per mL with known cannabinoid content (553 mg/mL)
Product formats	Single thick oil only	Sublingual oil and vape cartridge with format-specific formulas
THCa preservation	No — fully decarboxylated by heat	Yes — THCa included as a separate ingredient at 1,500 mg
Evidence approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

Why OilWell’s Formulas Diverge From Traditional RSO

Multi-cannabinoid approach: Traditional RSO relied on whatever single strain the maker grew. OilWell’s formulas intentionally include seven cannabinoids because the entourage-effect literature suggests potential benefit from cannabinoid diversity, even though robust clinical proof of whole-formula synergy remains limited [20][29].

Terpene preservation and addition: Traditional RSO had essentially no terpene content. OilWell includes live terpenes at 5% with a specific seven-terpene profile because terpene bioactivity is plausible and supported at the preclinical level [20][21][23][24][25][26][27][28][29].

THCa as a separate ingredient: Traditional RSO fully decarboxylated everything. OilWell’s sublingual formula includes THCa at 1,500 mg as a distinct ingredient, preserving the acidic precursor because the THCa literature suggests potentially relevant non-psychoactive bioactivity that is lost when THCa converts to THC [12].

Reduced delta-9 THC dominance: Traditional RSO was 60-90% delta-9 THC. OilWell’s sublingual formula uses delta-9 THC at only 90 mg while incorporating delta-8 THC at 6,000 mg and distributing the remaining content across CBD (4,500 mg), CBG (3,000 mg), CBN (750 mg), and CBC (750 mg).

Product format innovation: Simpson envisioned only one format: oral oil from a syringe. OilWell offers both a 30 mL sublingual oil and a 1-gram vape cartridge, each with format-specific formulations acknowledging that different delivery routes have different pharmacokinetic profiles [14].

About OilWell Cannabis and the OilWell RSO Formula

The Origin of OilWell Cannabis

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. Colin grew up in McAllen, Texas — right across the river from Reynosa, Tamaulipas, Mexico. The McAllen-Reynosa area, known as the Borderplex, is one of the most economically challenged and dangerous regions along the U.S.-Mexico border. McAllen is a city of contrasts — vibrant culture and a thriving retail sector, yet deeply affected by poverty and limited opportunities outside of retail and healthcare. Reynosa, on the other hand, is an industrial hub plagued by violence and cartel activity, making it a harsh environment for anyone growing up there.

Colin’s childhood in McAllen was marked by exposure to both the opportunities and the challenges of life along the border. Early on, he learned to hustle, taking on risky work in transporting items across the border for various groups. Those early experiences exposed him to complexities and dangers. A lot of his best friends have been killed or are in prison because of the associated dangers. He has faced every form of violence imaginable, both in the streets and across the border. By sixteen, one way or another, he had to leave home for good.

Despite the dangers, Colin did not fall into the darkest paths available to him, like selling harder substances. Instead, he focused on cannabis, seeing it as a safer and more beneficial alternative. He grew up in the traditional cannabis world long before legalization, learning the plant intimately while operating in the shadows. Over time, he transitioned from those early, risky ventures to creating a legal, legitimate business in an industry he believes in.

Colin later became a formally trained software engineer and did custom development work for Baylor College of Medicine, one of the most prestigious medical institutions in the Texas Medical Center. That combination — deep cannabis plant knowledge plus medical-grade technical precision — would eventually define OilWell’s approach.

What this means for Mauritius: Colin’s story isn’t about privilege or corporate backing. It’s about survival, integrity, and building something real from hardship. In Mauritius, where communities value resilience and authenticity, this origin story matters. This isn’t a faceless corporation; it’s a company built by someone who understands suffering and refused to let others experience it without options.

Bentley’s Story: The Real Reason OilWell Exists

The company’s origin story begins with a dog named Bentley. Bentley was more than just a pet — he was family, a companion who stood by Colin through the toughest times. When Bentley fell seriously ill, veterinarians delivered the verdict no pet owner wants to hear: euthanasia was the only humane option. Bentley was paralyzed in his back legs. They said the pain medications would destroy his internal organs, causing him more pain and suffering. The choice was painful prolonged decline or immediate mercy killing.

But giving up on Bentley was not an option. Colin had already faced too much loss and seen too much suffering in his life. Bentley was a fighter, just like him, and Colin was not ready to let him go. In a desperate search for alternatives, he stumbled upon the healing properties of CBD — through a question that changed everything.

A kind-hearted rescue worker named Jessica asked Colin: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin had cannabis experience — but it was recreational. Getting high. He had never explored the therapeutic and medicinal applications. Jessica’s question exposed a blind spot that would become a mission.

Determined to save Bentley, Colin learned to create CBD golden paste — a specialized cannabinoid formula for pets. It was not a cure, but it was a lifeline — and it was hope. And that hope delivered something veterinary medicine said was impossible: Bentley got up. He walked over to Colin and brought him his ball to play. From paralyzed and facing euthanasia to fetching his ball. This was not placebo effect — dogs do not respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those ten years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced. Neurodegeneration led him to understand CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection. Dementia led him to CBC’s role in neurogenesis. Glaucoma led him to THC’s CB1 agonism for intraocular pressure reduction. Crippling arthritis led him to develop multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously.

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. CBD alone could not address neurodegeneration and dementia and glaucoma and arthritis simultaneously. Minor cannabinoids like CBG, CBN, and CBC became critical as Bentley aged. Pharmaceutical precision mattered — Bentley’s life depended on formula accuracy, not guesswork.

What this means for Mauritius: In Mauritius, where pets are often considered family, Bentley’s story resonates deeply. Every Mauritian pet owner understands that moment when a vet says there’s nothing more to do. Bentley’s story gives hope grounded in real outcomes. But more importantly, the decade of formulation knowledge Colin built keeping Bentley alive IS the foundation of the RSO formula that Mauritians can access today. This wasn’t theoretical research — it was ten years of real-world testing on a patient he loved more than anything.

Colin’s Personal Experience: PTSD, Benzo Addiction, and Peace Gummies

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey — a feat that is notoriously difficult and dangerous — using the cannabinoid knowledge he had developed keeping Bentley alive. The Peace Gummies formula that became an OilWell product was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, OilWell also offers the Peace Gummies formula in a vape form, which Colin personally uses to manage his insomnia and severe PTSD. This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

What this means for Mauritius: PTSD and benzo addiction exist in every community, including Mauritius. Veterans, trauma survivors, and people trapped in prescription cycles will recognize this experience. Colin’s personal journey makes OilWell credible to these populations in a way no corporate brand can be. When a Mauritian customer with anxiety or PTSD contacts us, they’re speaking to someone who has walked that path.

Doctors Use Our Formulas

Over time, the therapeutic benefits of cannabis that Colin first discovered through his efforts to save Bentley became the core of his work. He has developed formulas that doctors use for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been on making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

What this means for Mauritius: In Mauritius, where integrative medicine is growing but cannabis education is limited, the fact that actual physicians use these formulas is significant credibility. If you’re a Mauritian healthcare provider exploring cannabinoid options for patients, you’re not alone. OilWell’s formulas are designed for clinical precision.

ABC13 Media Recognition: Seven Features, Four Years, One Voice

Between September 2019 and April 2023, ABC13 Houston (KTRK) — the ABC affiliate serving the fourth-largest city in the United States — featured Colin Valencia and OilWell Cannabis in seven distinct news segments spanning business, law, medicine, community health, and politics. Five different ABC13 reporters sought Colin out across those years: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers. No other Houston cannabis operator appears with that frequency or across that breadth of subject matter during the same period.

What this means for Mauritius: Mainstream media validation from a major-market ABC affiliate establishes credibility that transcends geography. When Mauritians see that a Houston news organization — in America’s fourth-largest city, home to the world’s largest medical complex — repeatedly selected Colin as their primary cannabis expert, it demonstrates a level of trustworthiness that no marketing campaign could replicate. This is third-party verification of expertise, ethics, and community commitment.

The features documented:

• September 2019: CBD business boom (foundational quote: “I’m not trying to sell people snake oil”)
• March 2021: Entrepreneur ecosystem building and decriminalization
• May 2021: Delta-8 THC investigation (“Maybe you want to get high” — uncensored honesty)
• August 2021: COVID vaccine giveaway (1,000 caviar pre-rolls, ~$35,000 in product donated)
• October 2021: Delta-8 ban (proactive removal, warning other operators)
• October 2022: Biden marijuana pardon (Colin’s personal conviction history revealed)
• April 2023: Texas marijuana laws and industry “Renaissance”

What this means for Mauritius: The through-line across these features shows consistency, breadth of expertise, community action, and personal stakes. For Mauritian customers evaluating whether to trust a U.S.-based company, this media record demonstrates that OilWell has been vetted by independent journalists over four years — recognition that cannot be purchased.

Current Operations: Houston-Made, Mauritius-Accessible

Today, OilWell Cannabis operates from Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). The company has been operating since 2019, generates approximately one million dollars in annual revenue, maintains a near-5.0 Google rating, and is Texas DSHS licensed. All artwork, formulations, and packaging are created in-house in Houston, using only OilWell’s own recipes and ideas.

What this means for Mauritius: While we are physically based in Houston, our products are accessible to Mauritius. We ship internationally with full documentation, Certificates of Analysis, and customs support. Our Houston address and licensing are verifiable trust signals — we’re not a fly-by-night operation. When you order from Mauritius, you’re getting a product made in America’s medical capital, backed by four years of media-verified credibility.

The OilWell RSO Philosophy: Four Core Principles for Mauritius

1. Accessibility Over Gatekeeping

No medical card is required. Anyone age twenty-one or older can purchase. We ship nationwide across the United States and internationally to Mauritius and other countries where hemp-derived products with less than 0.3% delta-9 THC are permitted. Simpson believed medicine should be accessible to everyone; we built a product and distribution model that makes that accessible legally.

For Mauritian customers: You don’t need a prescription or medical authorization. As long as Mauritius permits the import of hemp-derived products with minimal delta-9 THC, you can order directly. We provide all documentation for customs.

2. Patient-Controlled Potency

THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or to decarboxylate it into delta-9 THC for full psychoactive potency. Simpson believed patients should control their own medicine; we engineered a product that puts that control in your hands through chemistry.

For Mauritian customers: This is revolutionary flexibility. If you work in Mauritius’s tourism sector, financial services, or any job requiring mental clarity, you can use the raw form during the day with zero impairment. If you need full therapeutic strength for nighttime pain or sleep, you can decarboxylate at home. One product serves multiple needs.

3. Open-Source Formulas

We publish our complete formulas publicly — every cannabinoid, every milligram amount, every percentage — so that anyone who cannot afford the product can source ingredients and make their own version. Simpson gave his oil away for free and taught people how to make it; we adapted that ethos for the modern marketplace.

For Mauritian customers: The complete formulas are published later in this guide. If you’re in Mauritius where import costs or shipping fees make the product prohibitively expensive, you have the recipe. We don’t gatekeep the knowledge. That’s the OilWell promise.

4. Evidence-Informed, Not Evidence-Overstating

The GENERAL KNOWLEDGE section in this document represents our commitment to honest education about what the science actually says. Simpson operated without access to peer-reviewed literature; we have that access and use it to distinguish between what is well-supported, what is emerging, and what is overstated.

For Mauritian customers: In a market where cannabis claims often outrun evidence, we give you the actual research — 29 peer-reviewed citations, evidence-tier assessments, and clear warnings about what we know and what we don’t. You deserve nothing less.

Farm Bill Compliance and the THCa Legal Framework for Mauritius

The 2018 Farm Bill (Agricultural Improvement Act) legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level in the United States. This legal framework is the foundation of our RSO product design.

Our RSO Sublingual Oil contains only 90 milligrams of delta-9 THC in the entire 30 mL bottle — 3 milligrams per milliliter — well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under U.S. federal law.

THCa — tetrahydrocannabinolic acid — is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC. This distinction is legally significant: THCa is Farm Bill compliant at the point of sale because it has not been converted to delta-9 THC.

The practical significance for Mauritius: You can purchase our product legally under U.S. law. When it arrives in Mauritius, you are responsible for complying with Mauritian law regarding hemp-derived products. We ship with full documentation, Certificates of Analysis (COAs), and receipts. International customers accept all customs and legal responsibility.

Important legal notice for Mauritius: THCa converts to delta-9 THC when heated. Mauritian law may treat this converted product differently than the raw product. We advise all Mauritian customers to verify current local regulations before decarboxylating. Our product is legal for export from the U.S. and import to Mauritius only if Mauritian law permits hemp-derived cannabinoid products. You assume all legal responsibility for your use and any decarboxylation decisions. Void where prohibited by Mauritian law.

The Decarboxylation Choice — Patient-Controlled Potency for Mauritius

Traditional RSO was always fully decarboxylated. The heat of solvent evaporation converted all THCa into delta-9 THC, leaving the patient with no choice about psychoactivity — the oil was always psychoactive.

Our sublingual formula contains 1,500 milligrams of THCa in its acidic, non-psychoactive form. This creates three distinct usage options for Mauritian customers:

Option 1 — Raw, no heat. All 1,500 milligrams stays as THCa — completely non-psychoactive. The THCa evidence profile describes potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. This option is compatible with work, driving, and daytime use with zero psychoactive impairment.

Option 2 — Fully activated, home decarboxylation. Heating the oil at 260°F (125°C) for 45 to 60 minutes in an oven-safe glass container converts 1,500 milligrams of THCa into approximately 1,315 milligrams of delta-9 THC. Combined with the existing 90 milligrams of delta-9 THC in the formula, this yields approximately 1,405 milligrams of total delta-9 THC. Combined with 6,000 milligrams of delta-8 THC, the activated product achieves psychoactive potency comparable to traditional illegal RSO — 100% legally, because decarboxylation occurs at your discretion after purchase in Mauritius.

Option 3 — Vape, auto-decarboxylation. The RSO Vape Cartridge vaporizes at 400 to 450°F, which instantly converts THCa to delta-9 THC with each inhalation. Every puff delivers freshly decarboxylated cannabinoids. This is the fastest-onset RSO delivery method available.

The conversion chemistry: THCa has a molecular weight of 358.47 g/mol. The conversion ratio is approximately 1 milligram THCa = 0.877 milligrams delta-9 THC after decarboxylation, reflecting the loss of a CO₂ molecule during the reaction.

What this means for Mauritius: This design puts the potency decision entirely in your hands — aligning with Rick Simpson’s principle that patients should control their own medicine, but implementing that principle through actual product chemistry. Whether you’re in Port Louis needing daytime functional relief without impairment, or in Flic en Flac seeking full therapeutic strength for nighttime pain, one product adapts to your needs.

Solvent-Free Production: Safety First for Mauritius

Our RSO is not an extraction product in the traditional sense. It is a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in a controlled production environment. No naphtha. No isopropyl alcohol. No butane. No extraction solvents are present in the finished product.

This approach eliminates the residual solvent risk that is one of the most significant safety concerns with traditional RSO production, as discussed in the Rick Simpson section.

The product uses organic MCT oil (medium-chain triglycerides) as the carrier base. MCT oil is a food-grade lipid carrier that facilitates cannabinoid absorption through sublingual tissue and provides a neutral taste profile — a significant improvement over the tar-like consistency and solvent-residual odor of traditional RSO.

Third-party lab testing covers cannabinoid potency, terpene profile, and safety panels including pesticides, heavy metals, residual solvents, and microbial contaminants. Certificates of Analysis (COAs) are available on request and accessible through our website.

What this means for Mauritius: Product safety is universal. In Mauritius, where consumer protection agencies work to ensure product quality, our testing approach aligns with international standards. When you order from Mauritius, you receive lab-tested product with full documentation — not a black-market extract of unknown purity.

Two Product Formats for Mauritian Needs

RSO Sublingual Oil — $129.99

• 30 mL bottle (1 fl oz)
• 16,590 mg total cannabinoids (553 mg per mL)
• Seven cannabinoids: CBD 4,500 mg, CBG 3,000 mg, delta-8 THC 6,000 mg, THCa 1,500 mg, delta-9 THC 90 mg, CBN 750 mg, CBC 750 mg
• Live terpenes at 5%: limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene
• Organic MCT oil base
• Graduated dropper for precise dosing in 0.1 mL increments
• Onset: 15 to 45 minutes (sublingual absorption)
• Peak effects: 1 to 2 hours
• Duration: 4 to 6 hours
• Bioavailability: 13 to 19 percent
• Approximately 40 to 60 doses per bottle depending on serving size

Perfect for Mauritians who need: Sustained relief throughout the day or night, precise dosing control, and the flexibility to choose between psychoactive and non-psychoactive use.

RSO Vape Cartridge — $49.99

• 1-gram cartridge
• 900 mg+ total cannabinoids
• Same six-cannabinoid ratio as sublingual formula (THCa auto-decarbs at vaping temperature)
• Live terpenes at 5%+
• 510-thread universal battery compatibility (works with standard vape batteries available in Mauritius)
• Onset: 1 to 2 minutes (fastest cannabinoid delivery method)
• Peak effects: 10 to 15 minutes
• Duration: 2 to 4 hours
• Bioavailability: 10 to 35 percent
• Automatic THCa decarboxylation at vaping temperature (400 to 450°F)

Perfect for Mauritians who need: Fast relief for breakthrough pain, nausea, or panic attacks. The vape format is discreet and portable, ideal for Mauritians working in hospitality or tourism who need immediate symptom management.

When to Use Each Format in Mauritius

Use case	Recommended format	Rationale
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration
Maximum bioavailability	Sublingual	13-19% absorption
Portability and discretion	Vape	Compact, no measuring required
Precise dosing control	Sublingual	Graduated dropper in 0.1 mL increments
Daytime non-psychoactive use	Sublingual (raw, no heat)	THCa stays inactive, zero impairment
Nighttime psychoactive use	Sublingual (decarbed) or Vape	Activated THCa + delta-8 THC

Competitive Comparison: Why OilWell for Mauritius?

OilWell RSO vs. Traditional Illegal RSO (What You Might Find in Mauritius)

If you’re in Mauritius searching for RSO through informal channels, you may encounter traditional RSO made with naphtha or isopropyl alcohol. Here’s what you need to know:

Dimension	Traditional Illegal RSO	OilWell RSO
Safety	May contain residual naphtha (benzene, toluene)	Solvent-free, third-party tested
Standardization	None — every batch different	Precise 553 mg/mL, lab-verified
Cannabinoids	Unknown THC concentration (60-90% estimated)	Seven defined cannabinoids at exact ratios
Terpene content	Destroyed by heat	5% live terpenes with seven-terpene profile
Legal risk	Schedule I substance (illegal in Mauritius)	Hemp-derived, Farm Bill compliant for export
Dosing precision	Guesswork from syringe	Graduated dropper, 0.1 mL increments
Availability	Black market, inconsistent	Ships legally to Mauritius with full documentation

OilWell RSO vs. CBD-Only Oils Available in Mauritius

Many Mauritian wellness shops sell CBD-only oils. Here’s how OilWell differs:

Dimension	Typical CBD Oil (Mauritius market)	OilWell RSO
Total cannabinoids	500-1,000 mg	16,590 mg (16x more)
Cannabinoid diversity	Usually CBD only	7 cannabinoids + 7 terpenes
Psychoactive option	No	Yes — via THCa decarboxylation
Clinical strength	Wellness supplement	Clinical-strength formulation
Evidence base	Limited to CBD research	Multi-cannabinoid evidence profiles
Price per mg	Often more expensive	$129.99 for 16,590 mg = $0.0078 per mg

Condition-Specific Usage Context for Mauritius

Important disclaimer: The following usage contexts are informed by cannabinoid research cited in the GENERAL KNOWLEDGE section and by our formulation rationale. They are not medical prescriptions, not FDA-approved treatment protocols, and not a substitute for professional medical care. These products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, are taking medications, are pregnant or nursing, or have any health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite Support (For Mauritian Cancer Patients)

• Pre-chemo: 0.5 to 1.0 mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2 to 3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support during treatment: 1.0 to 2.0 mL sublingual before bed (delivers 25 to 50 mg CBN)
• Evidence context: delta-8 THC antiemetic evidence [9], delta-9 THC nausea evidence [1][13], CBD anxiolytic buffering [3]

For Mauritians undergoing chemo at SSR National Hospital or private oncology centers: We understand this is an extraordinarily difficult time. Our multi-cannabinoid approach targets nausea from multiple angles. The vape format provides immediate relief when nausea strikes suddenly. The sublingual format provides sustained support. Always coordinate with your oncologist.

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy) — Common in Mauritius’s Agricultural Workers

• Daytime: 0.3 to 0.5 mL raw sublingual — provides anti-inflammatory cannabinoid exposure without psychoactive impairment
• Nighttime: 0.5 to 1.0 mL decarboxylated sublingual — combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset
• Evidence context: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

For Mauritian sugarcane workers, construction workers, and others with physically demanding jobs: Chronic pain is widespread. Traditional pain medications have limits and risks. Our raw sublingual option allows you to work without impairment while managing inflammation. The vape provides relief after a long day. The terpene caryophyllene specifically targets CB2 receptors involved in inflammatory pain.

Sleep Support — For Mauritius’s Insomnia Sufferers

• Before bed: 1.0 to 2.0 mL sublingual
• At 2.0 mL, this delivers 50 mg CBN — the dosage level investigated in 2024 sleep literature
• At 1.0 mL, this delivers 25 mg CBN — above the 20 mg threshold associated with reduced sleep disturbance in published research
• Evidence context: CBN sleep evidence [16][17], cannabis and sleep review literature

For Mauritians struggling with insomnia in humid coastal climates or stressful urban environments: Sleep disorders are common. Our CBN content is specifically formulated at research-supported levels. Combined with myrcene and linalool terpenes, this creates a sleep-support profile that goes beyond single-cannabinoid approaches.

Anxiety and Stress — For Mauritius’s High-Pressure Professionals

• Daytime functional relief: 0.3 mL raw sublingual — CBD and CBG address anxiety-related pathways without psychoactive impairment
• Nighttime: 1.0 mL sublingual — full cannabinoid profile including CBN for sleep architecture
• Evidence context: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage-effect evidence [20]

For Mauritians in finance, tourism management, or any high-stress profession: Anxiety can be debilitating. Our raw sublingual option allows you to remain fully functional at work while managing stress biochemically. The limonene terpene provides mood-support properties without sedation.

General Titration Principle for Mauritians

Start low, go slow. Begin with 0.25 to 0.5 mL sublingual and assess effects over 2 to 3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors. Mauritian customers should be especially mindful of hydration and nutrition, as cannabinoids can affect appetite and metabolism.

The Broader OilWell Product Portfolio

Beyond RSO, we produce a range of cannabinoid products, each developed from the formulation knowledge Colin built over Bentley’s ten-year journey and his own experience with PTSD and benzo withdrawal.

Asshole Peach — Our most popular product. Asshole Peach is a carefully formulated experience designed to provide a euphoric, long-lasting sensation. It is particularly favored by veterans for its ability to relieve pain and PTSD symptoms without being overly aggressive.

Peace Gummies — Developed directly from Colin’s own experience with PTSD and benzodiazepine addiction. Peace Gummies helped him quit Xanax cold turkey. The formula is also available in a vape form for quick relief — Colin personally uses the vape to manage his insomnia and severe PTSD on an ongoing basis.

Custom creations — We offer custom-made products tailored to the specific needs of individual customers. Whether it involves specific cannabinoid ratios, particular delivery formats, or formulations for unique health circumstances, we design targeted products on request. This includes formulations for vegans, diabetics, and those with specific dietary or health needs.

What this means for Mauritius: If you have specific dietary requirements (halal, kosher, vegan), health conditions, or need a custom cannabinoid ratio not available in our standard products, we can formulate it for you. Mauritius’s diverse population has diverse needs — we meet them.

Delivery and Global Accessibility to Mauritius

International Shipping to Mauritius

OilWell ships internationally and has already delivered to multiple countries across multiple continents. The THCa legal framework makes this possible: because the product contains less than 0.3% delta-9 THC at the point of sale, it meets the definition of a hemp-derived product under the 2018 Farm Bill and is shippable to jurisdictions with compatible hemp laws.

For Mauritian customers:

• All international packages include full documentation, Certificates of Analysis (COAs), and receipts for customs purposes
• Minimum flat-fee shipping applies; excessive international shipping costs are billed to the customer
• You are responsible for verifying legality in Mauritius and accept all customs and legal risk
• Contact us: (832) 416-2816 or [email protected]

Estimated shipping to Mauritius: 7-14 business days via USPS Priority Mail International or FedEx International. We recommend FedEx for faster customs clearance in Mauritius.

The Significance for Mauritius

Rick Simpson could not ship his oil anywhere — it was Schedule I, illegal to produce, possess, or transport. A Mauritian cancer patient or chronic pain sufferer can now potentially access the same clinical-strength multi-cannabinoid RSO formula that a Houston resident receives via same-day delivery. We built a product that can move across borders legally — completing a piece of Rick Simpson’s vision that prohibition made impossible during his lifetime of advocacy.

OilWell’s PANDEM1C SEO technology — a proprietary system with 14 million distinct geopolitical locations in its database and over 300 AI models — drives organic search visibility across six continents, making our products discoverable to Mauritian patients searching for RSO in English or French.

How the OilWell Formulas Connect to The Evidence

Every cannabinoid in our formula — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC — has its own evidence profile in the GENERAL KNOWLEDGE section. Every terpene — limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene — is covered with preclinical and review-level evidence.

The formulas published in this document are anchored to per-compound evidence summaries. We do not exempt ourselves from the same evidence standards applied to the broader field. Where our RSO guide page makes specific research claims about individual cannabinoids or terpenes, this document provides the source evaluation context — the same peer-reviewed citations, the same evidence-tier assessments, and the same cautious interpretation framework.

Our position — as stated on ABC13 in 2019 — is that people deserve the best possible version of the information so they can give it a fair shot and decide for themselves whether it is right or wrong for them. This document is the research foundation for that position.

GENERAL KNOWLEDGE: The Science Behind Every Compound

Research Method and Evidence Weighting

This section prioritizes sources in the following order: human clinical evidence, systematic reviews and meta-analyses, NIH and other institutional summaries, then mechanistic or preclinical literature when human data are sparse. That weighting matters here because the evidence base is not evenly distributed. Of the compounds listed, CBD and delta-9 THC have the strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes are still much more dependent on reviews, animal work, in vitro pharmacology, or early translational literature [1]-[29].

What this means for Mauritius: We don’t hide behind vague claims. We tell you exactly what level of evidence supports each compound. For Mauritian customers who value scientific rigor, this transparency is essential.

Institutional Baseline from NIH and Related Sources

• NCCIH states that the strongest established cannabinoid evidence is for certain rare epilepsies, chemotherapy-related nausea and vomiting, and appetite or weight-loss indications associated with HIV/AIDS. It also notes only modest evidence for chronic pain and multiple-sclerosis-related symptoms, with many other claimed uses still in early-stage research [1].
• NCCIH emphasizes that the FDA has not approved the cannabis plant itself for medical use, although purified CBD and synthetic THC-like drugs have specific approvals [1].
• Safety concerns repeatedly highlighted include impairment, motor vehicle crash risk, cannabis use disorder, pregnancy-related concerns, accidental pediatric exposure, contamination or labeling inaccuracy, and THC-vape lung-injury concerns [1].
• NCCIH specifically warns that over-the-counter CBD products may differ from their labels and that CBD itself has been associated with decreased alertness, gastrointestinal effects, liver-related adverse effects, and drug interactions [1].

What this means for Mauritius: These institutional positions matter. In Mauritius, where healthcare providers may be less familiar with cannabinoids, referencing NIH positions provides credibility and safety context.

Cannabinoid Profiles

CBD

• Evidence profile: Strongest human evidence in our formula, especially for seizure disorders [1][2].
• Anxiety: 2024 systematic review found significant anxiolytic signal but stressed limited clinical sample [3].
• Pain: 2024 review concluded promising but heterogeneous, limiting broad analgesic claims [4].
• Sleep: 2023 review found literature methodologically weak [5].
• Safety: 2023 review found real signal for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products [6]. NCCIH flags diarrhea, sleepiness, appetite change, mood effects, liver-function abnormalities, and drug-drug interactions [1].
• Bottom line for Mauritius: CBD is the most evidence-developed nonintoxicating cannabinoid, but strong evidence is concentrated in specific indications rather than broad wellness claims.

CBG

• Evidence profile: Mostly review-level and preclinical; human evidence remains sparse [7][8].
• Pharmacology: CBG is the biosynthetic precursor to several major cannabinoids, with interactions spanning cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A-related signaling [7].
• Potential areas: Neurologic disorders, inflammatory bowel disease, antibacterial activity — primarily pharmacology-led hypotheses [7][8].
• Caution: CBG is already being sold commercially while the evidence base remains thin [7].
• Bottom line for Mauritius: CBG is a promising minor cannabinoid with limited clinical validation. Claims should be conservative.

Delta-8 THC

• Evidence profile: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 THC [9]-[11].
• Comparative pharmacology: 2022 review concluded delta-8 and delta-9 have broadly similar behavior, but delta-8 appears less potent due to weaker CB1 affinity [9].
• Public health: 2023 scoping review found evidence base dominated by animal studies, product chemistry, and public-health concerns rather than strong human trials [10]. Reports of adverse consequences noted [10].
• Manufacturing: Commercial interest tied to greater stability and easier synthesis relative to naturally scarce plant levels [11].
• Bottom line for Mauritius: Delta-8 THC is a psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, and manufacturing-quality uncertainty. Treat it seriously.

THCa

• Evidence profile: Important chemically and formulation-wise, but low on direct human therapeutic evidence [12].
• What it is: Acidic precursor of THC. Decarboxylates into THC during heating and can change over time during storage [12].
• Psychoactivity: THCa itself does not produce THC’s psychoactive effects — but only if it stays in acidic form and is not decarboxylated [12].
• Research status: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but not established human outcomes [12].
• Bottom line for Mauritius: THCa is best understood as a precursor molecule whose interpretation depends heavily on route, temperature, processing, and storage. Any claim must account for possible conversion to THC.

Delta-9 THC

• Evidence profile: Strongest human evidence of psychoactive cannabinoids, but also clearest adverse-effect burden [1][13]-[15].
• Institutionally supported: NCCIH identifies relevance to chemotherapy nausea, HIV/AIDS appetite, some MS and pain outcomes [1].
• Pain evidence: 2022 systematic review found high-THC products may provide short-term pain benefit but increase dizziness, sedation, nausea, and discontinuation [13].
• Pharmacokinetics: Inhaled THC: effects within seconds to minutes, peak 15-30 minutes, taper over few hours. Oral THC: later onset, later peak, longer duration [14].
• Mental health risk: 2025 systematic review found consistent unfavorable associations with psychosis/schizophrenia outcomes and cannabis use disorder, with concerning signals for anxiety and depression [15].
• Broader safety: Anxiety/panic at high doses, tachycardia, blood-pressure changes, dependency, withdrawal, pregnancy concerns, accidental pediatric exposure, vape-related lung injury [1][14][15].
• Bottom line for Mauritius: Delta-9 THC has legitimate therapeutic relevance but carries clearest intoxication, psychiatric, and dose-related safety liabilities. Use with caution and medical guidance.

CBN

• Evidence profile: Weak human evidence; marketing ahead of data [12][16][17].
• Marketing vs. reality: Reputation for sleep, but 2021 review screened 99 human-study abstracts and found no clinical trials using validated sleep questionnaires or polysomnography to substantiate strong sleep-promoting claims [16].
• 2024 sleep literature: Updated review concluded overall cannabinoid sleep research still doesn’t match real-world use scale [17].
• Chemical context: THC can degrade toward CBN under certain conditions [12].
• Bottom line for Mauritius: CBN is clearest example where cultural reputation is stronger than current clinical evidence [16][17].

CBC

• Evidence profile: Emerging, intriguing, overwhelmingly preclinical or review-based [18][19].
• Pharmacology: 2024 review argues CBC has distinct pharmacodynamics, pharmacokinetics, and receptor behavior, highlighting antinociceptive, antibacterial, and anti-seizure areas [18].
• Older literature: Anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesia, possible neurobiological/antiproliferative relevance — not strong patient-facing evidence [19].
• Safety caveat: Over-the-counter CBC products already being sold despite little evidence establishing clinical efficacy or safety [18].
• Bottom line for Mauritius: CBC is scientifically credible minor cannabinoid deserving more research, not already-validated clinical active [18][19].

Terpene Profiles

Limonene

• Evidence profile: Largely review and preclinical [20]-[22].
• Potential activity: 2021 review describes antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory effects — mostly from nonhuman/non-cannabis literature [21].
• Safety note: Limonene oxidation products (hydroperoxides) are clinically relevant contact allergens [22].
• Bottom line for Mauritius: Biologically active and widely discussed, but cannabis-specific therapeutic claims should stay conservative.

Myrcene

• Evidence profile: Mostly preclinical, very limited human evidence [20][23].
• Research summary: 2021 review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties but explicitly states human studies are lacking [23].
• Interpretation caution: Often invoked as proven sedative explaining couch-lock, but that is stronger claim than human evidence supports [20][23].
• Bottom line for Mauritius: Plausible bioactive terpene, but compound-specific clinical claims about mood, pain, or sedation remain far ahead of definitive human proof.

Caryophyllene

• Evidence profile: Among most mechanistically interesting because of direct cannabinoid-system relevance, but still mostly preclinical [24].
• Why it stands out: 2021 review describes beta-caryophyllene as selective CB2 receptor agonist — unusual and especially relevant pharmacologically [24].
• Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective — human clinical confirmation limited [24].
• Bottom line for Mauritius: Strongest candidate for terpene with cannabinoid-system significance, but should not be described as clinically proven.

Pinene

• Evidence profile: Promising preclinical literature, weak human confirmation [20][25].
• Brain-health framing: 2021 review found antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasized lack of well-designed clinical trials [25].
• Interpretation caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC cognitive effects remain hypotheses rather than settled facts [20][25].
• Bottom line for Mauritius: Deserves scientific attention, but strong cognition-related claims should be presented as exploratory.

Linalool

• Evidence profile: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26].
• Research summary: Repeatedly discussed in relation to stress, mood, brain-health pharmacology. 2021 brain-health review found enough preclinical signal to justify continued investigation while emphasizing lack of robust human trials [25].
• Additional literature: Review literature discusses possible antidepressant mechanisms, but remains translational rather than definitive [26].
• Safety note: Oxidized linalool hydroperoxides are recognized allergens [22].
• Bottom line for Mauritius: Scientifically credible bioactive terpene, but current evidence supports cautious phrasing.

Humulene

• Evidence profile: Translationally interesting, but early [20][27].
• Scoping-review findings: 2024 review analyzed 340 articles, found broad preclinical evidence for anti-inflammatory effects, with some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27].
• Interpretation caution: Findings valuable for hypothesis generation, but do not yet establish consistent human efficacy [27].
• Bottom line for Mauritius: One of more interesting terpene research targets, but remains far from clinically settled.

Terpinolene

• Evidence profile: One of least clinically characterized terpenes [20][28].
• Systematic-review findings: 2021 review screened 2,449 records, included 57 studies, concluding terpinolene has range of reported biological effects but evidence base dominated by in silico, in vitro, and animal studies [28].
• Interpretation caution: Even recent cannabis entourage reviews frame terpene benefits as exploratory, not established compound-specific clinical effects [20].
• Bottom line for Mauritius: Biologically interesting, but among listed terpenes remains especially underdeveloped clinically [20][28].

Research Limits and Interpretation

• Evidence base is highly uneven. CBD and delta-9 THC support most detailed human-facing statements; rest require more caution [1]-[29].
• Whole-cannabis extract data, purified-molecule data, semisynthetic cannabinoid data, and terpene-only data are not interchangeable. Common error is letting evidence from one category stand in for another.
• Minor cannabinoids and terpenes are commercially interesting precisely because underexplored, but that also means claims often become inflated.
• Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, and route-dependent pharmacokinetics all materially affect interpretation [1][10][11][14].
• For THCa, chemistry is destiny: storage and heating can change actual exposure profile by converting acidic cannabinoids into neutral cannabinoids such as THC [12].

Common Overstatements to Avoid (Especially Important for Mauritian Customers)

• Overstatement: CBN is clinically proven sleep cannabinoid.
  More accurate: Sleep evidence for CBN remains weak, with no strong validated-trial base [16][17].
• Overstatement: Myrcene is proven human sedative explaining couch-lock.
  More accurate: Myrcene has plausible preclinical bioactivity, but direct human proof limited [20][23].
• Overstatement: Terpenes have proven entourage effects in patients.
  More accurate: Entourage hypotheses influential and worth studying, but robust clinical proof remains limited [20][29].
• Overstatement: THCa is always nonpsychoactive.
  More accurate: THCa itself is not THC, but heating and processing can convert THCa into THC [12].
• Overstatement: Delta-8 THC is safe because hemp-derived.
  More accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing and testing concerns [9]-[11].

Practical Takeaways for Our Mauritian Customers

• Most evidence-developed actives: CBD and delta-9 THC.
• Delta-8 THC is not trivial; it’s psychoactive with less robust safety/efficacy characterization than delta-9 THC.
• THCa meaningfully changes with processing; should not be interpreted same way in raw, gently handled, and heated formats.
• CBG, CBN, and CBC are scientifically credible but clinically immature compared with CBD and THC.
• Listed terpenes likely highly relevant to aroma, flavor, and potentially some biologic activity, but compound-specific human therapeutic claims should be made carefully and only where directly supported.

RSO Sublingual Oil Formula (Open-Source)

Cannabinoid	Amount
CBD	4,500 mg
CBG	3,000 mg
Delta-8 THC	6,000 mg
THCa	1,500 mg
Delta-9 THC	90 mg
CBN	750 mg
CBC	750 mg
Total Cannabinoids	16,590 mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30 mL bottle
• Active cannabinoids per mL: 553 mg
• Carrier: Organic MCT oil
• Price: $129.99 USD

For Mauritian DIY makers: If you cannot afford $129.99 or shipping costs to Mauritius are prohibitive, this is your recipe. Source individual cannabinoid distillates and isolates from reputable suppliers (ensure they ship to Mauritius), mix in these exact ratios using organic MCT oil as carrier. This is the formula that took ten years to perfect. It’s yours to use.

RSO Vape Cartridge Formula (Open-Source)

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1 Gram cartridge
• Thread: 510 universal (compatible with standard vape batteries in Mauritius)
• Price: $49.99 USD

For Mauritian DIY makers: This percentage-based formula is designed for vape cartridge filling. Requires professional equipment for safe preparation. We recommend purchasing the finished cartridge unless you have extraction/formulation experience.

Terpene Profile (Both Products)

• Limonene: Citrus-bright, mood-supporting
• Myrcene: Herbal, relaxing properties
• Caryophyllene: Pepper/spice, CB2 agonist for inflammation
• Pinene: Forest-fresh, clarity-enhancing
• Linalool: Floral (lavender), calming
• Humulene: Earthy/woody, anti-inflammatory
• Terpinolene: Piney/fruity, complex effects

Flavor and aroma: The combined profile is rich, layered, and natural — nothing like the harsh, solvent-residual taste of traditional RSO. For Mauritian palates accustomed to complex spice profiles in cuisine, this terpene blend will be sensorially familiar and pleasant.

Bentley’s CBD Golden Paste Recipe (Original Open-Source Formula)

We published this recipe years before the RSO formulas — the original open-source formula that saved Bentley:

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1 to 2 teaspoons freshly ground black pepper (important for absorption)
• CBD oil (dosage depends on pet size and needs; consult a veterinarian)

Instructions:

1. Mix turmeric and water in saucepan, stir over low heat until thick paste forms (7-10 minutes). Add more water if too thick.
2. Add coconut oil and pepper. Stir until thoroughly mixed.
3. Cool and store in refrigerator for up to two weeks.
4. Add small amount of CBD oil to paste before giving to pet, adjusting dosage based on weight and health needs. Start low and increase gradually.
5. Mix small amount with pet’s food once or twice daily. Monitor for changes. Consult veterinarian if concerns arise.

What this means for Mauritius: If you’re a Mauritian pet owner facing a similar crisis with your dog or cat, this recipe is yours. It’s free, it’s tested, and it worked on Bentley when veterinary medicine said there was no hope. Dogs don’t respond to placebo — this is real.

Frequently Asked Questions for Mauritian Customers

Q: Is it legal to ship RSO to Mauritius?
A: We ship hemp-derived products containing less than 0.3% delta-9 THC, which are legal for export under U.S. Farm Bill. You must verify that Mauritian law permits import and possession of such products. We provide full documentation for customs.

Q: Will I get high from the sublingual oil?
A: Only if you choose to. In its raw form, the high THCa content is non-psychoactive. If you decarboxylate by heating, it becomes highly psychoactive. You control this.

Q: How long does shipping to Mauritius take?
A: Typically 7-14 business days via USPS Priority Mail International or FedEx International. FedEx generally clears Mauritian customs faster.

Q: Can I use this while working in Mauritius’s tourism industry?
A: Yes, use the raw (non-decarboxylated) sublingual oil during work hours for zero impairment. The vape or decarboxylated oil should be used only when impairment is acceptable (e.g., at home).

Q: Is this safe to use with my other medications?
A: CBD can interact with certain medications, particularly those metabolized by the liver. Consult your Mauritian physician or pharmacist before combining with other drugs.

Q: How do I know the product is real and not fake?
A: Every shipment includes a Certificate of Analysis (COA) from a third-party lab showing exact cannabinoid content. The COA QR code is verifiable online. Our ABC13 media record provides independent verification of our legitimacy.

Q: Why is it expensive?
A: You’re getting 16,590 mg of total cannabinoids across seven compounds, lab-tested, with published formulas. That’s 16x more cannabinoids than typical CBD oils. The price per milligram is actually lower than most products available in Mauritius.

Q: What if I can’t afford it?
A: The complete formula is published in this guide. If you can source individual cannabinoid distillates that ship to Mauritius, you can make it yourself. That’s our open-source promise.

Q: Does this cure cancer?
A: No product has been proven to cure cancer in humans. Preclinical research on cannabinoids is interesting and ongoing, but not conclusive. Use RSO as a complementary approach alongside proven medical treatments, not as a replacement.

Q: Can I travel within Mauritius with this product?
A: Within Mauritius, you are subject to Mauritian law. Keep the product in its original packaging with the COA. Do not carry the vape cartridge on flights due to battery restrictions. The sublingual oil is travel-friendly.

Safety Warnings and Legal Disclaimers for Mauritius

Age requirement: 21+ for all RSO products.

FDA disclaimer: These products have not been evaluated by the Food and Drug Administration. They are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Consult a healthcare provider before use.

Safety warnings:

• May cause drowsiness or impairment. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.
• Keep out of reach of children and pets.
• Do not use if pregnant or nursing.
• Consult your physician if you have a medical condition or take medications, especially in Mauritius’s polypharmacy context where drug interactions are a real concern.
• Store in a cool, dry place away from direct sunlight. In Mauritius’s tropical climate, refrigeration is recommended after opening.

Legal responsibility: Mauritian customers are solely responsible for verifying import, possession, and use compliance with Mauritian law. OilWell assumes no legal responsibility for your use or decarboxylation decisions. Products are void where prohibited by Mauritian law.

Important note for Mauritius: While our products are legal for export from the U.S., cannabis laws in Mauritius may differ. As of our last update, Mauritius has not legalized recreational cannabis, but hemp-derived products may fall under different regulations. We strongly advise consulting a Mauritian legal expert or customs official before ordering.

How to Order RSO in Mauritius

Step 1: Verify Legal Status

Confirm that Mauritian law permits import of hemp-derived cannabinoid products containing <0.3% delta-9 THC. Contact Mauritius Customs if uncertain.

Step 2: Choose Your Format

• Sublingual Oil: For sustained relief, precise dosing, daytime non-psychoactive use (raw), or nighttime psychoactive use (decarbed)
• Vape Cartridge: For fast relief, portability, acute breakthrough symptoms

Step 3: Place Your Order

Visit OilWellCBD.com and select your product. At checkout:

• Enter your Mauritian shipping address
• Select “International Shipping”
• Add any special customs instructions
• Payment: We accept major credit cards and cryptocurrency for international orders

Step 4: Customs Documentation

We automatically include:

• Certificate of Analysis (COA) showing cannabinoid content
• Invoice with product description as “hemp-derived cannabinoid oil”
• Farm Bill compliance letter
• Copy of our Texas DSHS license

Step 5: Track Your Shipment

You’ll receive tracking info via email. Monitor progress through customs in Mauritius. If customs contacts you, provide the COA and documentation we included.

Step 6: Responsibly Receive and Use

Upon arrival in Mauritius:

• Inspect package for customs seals
• Verify product matches COA
• Store properly (refrigerate after opening due to Mauritius climate)
• Start with low dose and titrate slowly
• Consult Mauritian healthcare provider

Contact us for Mauritius orders: (832) 416-2816 or [email protected]. We have experience shipping to Mauritius and can answer specific customs questions.

The Through-Line: Why Mauritians Can Trust OilWell

The seven ABC13 features, Bentley’s story, Colin’s personal conviction history, our open-source formulas, and the 29 peer-reviewed citations in this document all point to one conclusion: OilWell is built on earned credibility, not purchased marketing.

For Mauritian customers evaluating whether to trust a U.S.-based cannabis company:

• Media verification: Houston’s #1 news source vetted us for four years
• Legal compliance: Farm Bill compliant, Texas DSHS licensed
• Transparency: We publish our exact formulas — no trade secrets
• Science: Every claim is tied to peer-reviewed research
• Community: $35,000 in free product for COVID vaccination, proactive ethics during Delta-8 ban
• Personal stakes: Our founder has lived the consequences of cannabis criminalization

Recognition cannot be purchased — it can only be earned. In Mauritius’s tight-knit communities, reputation matters. Our reputation is documented by independent journalists, verified by third-party labs, and proven by the customers who use our products to manage conditions that conventional medicine couldn’t solve.

Final Thoughts for Our Mauritian Friends

We know that searching for RSO in Mauritius can feel overwhelming. You’re likely dealing with serious health challenges — cancer, chronic pain, PTSD, insomnia — and you need honest answers, not false hope. That’s why we built OilWell differently.

We don’t claim to cure cancer. We do provide the most comprehensive, evidence-based, legally accessible multi-cannabinoid RSO formula available globally. We publish our formulas so you can verify every claim. We ship to Mauritius so you don’t have to rely on black-market products of unknown quality. And we answer your questions directly because that’s what we’d want if we were in your shoes.

From Houston to Mauritius: The distance is vast, but the need for honest cannabinoid medicine is the same. We’re here when you’re ready.

Order now for delivery to Mauritius: OilWellCBD.com

Questions about shipping to Mauritius: (832) 416-2816 or [email protected]

View our complete RSO guide: OilWell Cannabis RSO Guide

Follow us: @oilwellcbd on Instagram for customer stories, dosing tips, and updates

This content is provided for educational purposes. All medical claims have been reviewed against current peer-reviewed literature. Last updated: March 2026.

---